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ABSTRACT 
Ion homeostasis is essential for proper neuronal function, since changes in intra- or 
extracellular ion concentrations can cause neuropathological conditions including 
seizures and neuropathic pain. The Clˉ gradient determines the strength and polarity of 
GABAergic neurotransmission. It is established by the activity of cation-chloride 
cotransporters (CCCs), the K+-Clˉ co-transporter 2 (KCC2) and the Na+-K⁺-2Clˉ co-
transporter 1 (NKCC1). 
To investigate how changes in Clˉ concentration in inhibitory neurons affect GABAergic 
neurotransmission and overall excitability, KCC2 expression was inhibited in 
parvalbuminergic (PV+) interneurons of C57BL/6 mice. 
KO mice showed an ataxic gait, spontaneous epileptic seizures and a shortened life 
span. Immunohistochemistry revealed a loss of PV+ neurons in the hippocampus and 
the layer V/VI of the somatosensory cortex without detectable morphological changes. 
Field potential recordings showed altered short and long-term plasticity and a switch 
from increased inhibition at 8 weeks to enhanced excitation at 21 weeks. In vivo 
studies suggested increased anxiety and a significant delay of PTZ induced seizures in 
KO mice. 
This study suggests a role of KCC2 for proper Cl¯ homeostasis in PV+ interneurons and 
impressively showed how impairment in GABAergic inhibition contributes to balanced 
brain activity. Furthermore, our results demonstrate a role of PV+ interneurons for the 
stress axis, neuronal excitability and higher brain functions like learning and memory. 
 
 
X 
 
ZUSAMMENFASSUNG 
Die Ionenhomöostase spielt bei der Regulation physiologischer neuronaler Prozesse 
eine herausragende  Rolle. Sowohl intra- als auch extrazelluläre 
Ionenkonzentrationsänderungen können zu neurologischen Störungen führen. In 
Neuronen ist die Chloridionen (Clˉ)-Konzentration von besonderem Interesse, da diese 
die Stärke und Polarität der GABAergen Transmission bestimmt. Die Konzentration 
wird dabei hauptsächlich durch die Aktivität von Kationen-Chlorid-Kotransportern 
(CCCs) eingestellt. Dabei kommt sowohl dem Kalium-Chlorid-Kotransporter 2 (KCC2) 
als auch dem Natrium-Kalium-Chlorid-Kotransporter 1 (NKCC1) eine besondere 
Bedeutung zu. 
In parvalbuminergen (PV+) Interneuronen von C57BL/6-Mäusen erfolgte die gezielte 
Hemmung der KCC2-Expression, um den Einfluss einer veränderten Clˉ-Konzentration 
in inhibitorischen Neuronen auf die GABAerge Neurotransmission und die Erregbarkeit 
des neuronalen Gewebes zu untersuchen.  
Interessanterweise zeigten diese konditionalen KO-Mäuse einen sehr auffälligen 
Phänotyp, gekennzeichnet durch Gangstörung, spontane epileptische Anfälle sowie 
eine verkürzte Lebensspanne. In immunhistochemischen Untersuchungen stellte sich 
ein Verlust parvalbuminerger Interneurone sowohl im Hippokampus als auch in der 
Schicht V/VI des somatosensorischen Kortex heraus. Weitere morphologische 
Veränderungen waren nicht zu beobachten. Extrazelluläre Ableitungen an akuten 
Hirnschnitten offenbarten eine veränderte Kurz- und Langzeitplastizität und eine 
Verschiebung von erhöhter Inhibition im Alter von 8 Wochen zu  verstärkter neuronaler 
Erregbarkeit mit 21 Wochen im konditionalen KO. Die durchgeführten in vivo-Versuche 
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deuten auf eine Angststörung hin und demonstrieren eine signifikante Verzögerung 
PTZ-induzierter Krampfanfälle. 
Diese Arbeit weist auf eine herausragende Rolle von KCC2 bei der Regulation der 
intrazellulären Chloridkonzentration parvalbuminerger Neurone hin. Sie zeigt, wie eine 
gestörte Chloridhomöostase parvalbuminerger Interneurone die  GABAerge Inhibition 
verändert und somit die neuronale Erregbarkeit beeinflusst. Darüber hinaus 
unterstreichen die gewonnenen Resultate die besondere Wichtigkeit dieser 
Interneurone für die hormonelle Feinregulation der Stressachse. 
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INTRODUCTION 
EPILEPSY 
According to a report of the U.S. Institute of Medicine (England et al., 2012) epilepsy is 
the fourth most common neurological disorder that affects 1 in 26 people at some point 
in their lifetime. 
Clinically it comprises a broad spectrum of disorders with various seizure types and 
causes, a range of severities and an array of coexisting conditions that affects people 
of all ages, with onset most often occurring in childhood or older adulthood (Hauser, 
1995). More than 25 epilepsy syndromes can be  distinguished (Berg et al., 2010) with 
epilepsy defined as the occurrence of two or more unprovoked seizures separated by 
at least 24 hours (ILAE, 1993). 
During the last decade classification and characterisation of the subtypes improved, 
making a successful treatment more likely. The epilepsies can be broadly grouped into 
three classes: generalised epilepsy; focal epilepsy; and epileptic encephalopathy. 
Within each class, several specific syndromes are defined by differences in specific 
seizure types, electroencephalogram (EEG) patterns, age of onset and disease 
progression. 
The genetic contribution to epilepsies is known since the antiques and well established 
through family and twin studies. 20-30 % of epilepsies are caused by acquired 
conditions such as stroke, tumour or head injury. The other 70–80 % are thought to be 
due to genetic risk factors (Hildebrand et al., 2013). Since whole genome sequencing 
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became affordable and exome sequencing is well established as a standard 
technology, many genes associated with specific types of epilepsies were discovered 
(Helbig and Lowenstein, 2013, McTague et al., 2016, Oliver et al., 2014). The spectrum 
includes genes of chromatin remodelling, ion channels and neurotransmitter receptors, 
intracellular signalling, metabolism and synaptic vesicle cycle (Myers and Mefford, 
2015). 
FIGURE 1: LIST OF SELECTED GENES INVOLVED IN THE CONTROL OF 
EXCITATION/INHIBITION BALANCE. Mutations in the displayed genes impair synaptic 
inhibitory transmission from early development through maturation of adult GABA 
neurotransmission. Many others genes remain to be functionally assigned to their target 
location and impact on excitation and inhibition balance in epileptic microcircuits (adapted from 
Noebels 2015). The list of genes is displayed in the appendix. 
This diversity shows the large number of molecular pathways involved. Many of these 
genes identified by whole genome or exome sequencing have been further 
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investigated in mouse models and a major fraction of those regulate the birth, 
development, or function of inhibitory interneurons (figure 1; (Noebels, 2015)). During 
the last years publications speculate on the importance of GABAergic inhibition to 
trigger or maintain epileptic seizures (Avoli et al., 2016, Campbell et al., 2015, de Curtis 
and Avoli, 2016, Ellender et al., 2014, Kahle et al., 2016, Kaila et al., 2014b). 
INTERNEURONS AND INHIBITION 
Although glutamatergic excitatory synapses account for the vast majority of synapses 
in the brain, inhibitory synapses play an essential role in the nervous system. They are 
not only controlling excitation but also coordinating activity among networks of neurons. 
The coordination of activity is important for neuronal processing of information. Recent 
studies in animals and humans indicate that subtle perturbations in inhibition lead to 
epilepsy and psychiatric disorders like schizophrenia, autism or contributes to the 
phenotype of Angelman syndrome (Marín, 2012, Lewis et al., 2005). 
INTERNEURON SUBTYPES 
Inhibitory interneurons are a heterogeneous group of GABAergic or glycinergic neurons 
that constitute approximately 20% of cortical neurons and 10% of hippocampal neurons 
(Marín, 2012, Olbrich and Braak, 1985). They mediate the precise gating of information 
through specific signalling pathways by controlling the amounts of excitatory and 
inhibitory inputs that individual neurons receive both spatially and temporally (Vogels 
and Abbott, 2009). 
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Various subpopulations can be distinguished by a combination of morphological, 
physiological and molecular attributes. Classification occurs according to the spatial 
localisation of the synapse, expression of specific calcium-binding proteins (CBPs) or 
the firing pattern (figure 2B). For example, Martinotti cells form synapses onto the 
dendrites of pyramidal cells, whereas basket cells and chandelier cells primarily contact 
the soma and axon initial segment (AIS) of pyramidal cells (Marín, 2012). 
As the spatial location of synapses is one of the features that determine the effect of 
interneurons on a postsynaptic target (Somogyi and Klausberger, 2005), each class of 
interneurons modulates pyramidal cell function in a specific manner. Based on 
histochemical markers, inhibitory cells can be divided into three non-overlapping 
categories in mice: those that express parvalbumin (PV), somatostatin (SST), and 5-
hydroxytryptamine (serotonin) receptor 3a (5HT3aR), and one overlapping class of 
SST and calretinin (CR) positive cells (figure 2A) (Somogyi and Klausberger, 2005, 
Freund and Buzsaki, 1996, Ascoli et al., 2008, Rudy et al., 2011). 5HT3aR is the only 
known murine serotonergic ionotropic receptor and is present exclusively in GABAergic 
neurons (Ferezou et al., 2002, Morales and Bloom, 1997, Puig et al., 2004). Although 
these classes don't account for all inhibitory interneurons - a small number of 
interneurons express other less common markers like vasoactive intestinal peptide 
(VIP), Calbindin (CB) or neuropeptide Y (NPY) - they represent the vast majority (80–
90 %) of all inhibitory cells (Rudy et al., 2011, Pfeffer et al., 2013). 
 The interneuron subpopulations also display different electrophysiological properties 
as e.g. their spiking pattern. 
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FIGURE 2: SUBPOPULATIONS OF GABAERGIC NEURONS. A| Classification of
GABAergic interneurons in adult neocortex. The majority belongs to one of three groups defined
by the expression of parvalbumin (PV), somatostatin (SST), and the ionotropic serotonin receptor
5ht3a (5HT3aR). In turn, each subgroup consists of several functionally distinct types or classes
of interneurons (adapted and modified from Rudy et al. 2011). B| Interneuron cell types are
defined using a combination of criteria based on morphology, connectivity pattern, synaptic
properties, marker expression and firing pattern. The highlighted connections define fast-spiking
cortical basket cells (modified from Kepecs and Rudy 2014).  
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A correlation between spiking pattern and the already mentioned histochemical 
markers was reported by several publications. In the majority of cases CR positive 
interneurons are referred to as accommodating or irregular-spiking neurons (Porter et 
al., 1998); CB positive ones represent bursting interneurons (Kawaguchi and Kubota, 
1993) and PV positive ones are fast-spiking interneurons (Ascoli et al., 2008, 
Kawaguchi and Kubota, 1993, Chow et al., 1999). This correlation does not seem to be 
distinct and ideally the characterisation of a neuron will consider all three sets of criteria 
- morphology, molecular biology, and physiology (Ascoli et al., 2008). 
PV+ NEURONS 
PV is a calcium-binding protein that is involved in Ca2+ signalling and many 
physiological processes. PV is expressed in fast-contracting muscles as well as in the 
brain and some endocrine tissues. In the cerebral cortex PV is found in subsets of 
GABAergic neurons, which are present in all areas of the neocortex and in all layers 
except layer I (Celio and Heizmann, 1981). Morphologically they can be divided into at 
least two categories of GABAergic local circuit neurons: basket cells and chandelier 
cells (figure 3) (Hendry et al., 1989, Jones and Hendry, 1986, Lewis and Lund, 1990), 
but some also display other morphological features like bi-stratisfied cells or oriens-
lacunosum-moleculare neurons (OLM cells). In basket cells, the axon forms a basket-
like arrangement around the principal cell somata and proximal dendrites. In axo-
axonic cells, the axon of the interneuron follows the axon initial segment (AIS) of the 
principal cell, resulting in a chandelier-like configuration (figure 3). By controlling a large 
set of principal cells at the site of action potential initiation and electrical coupling of 
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dendrites over gap junctions, PV+ interneurons can mediate powerful inhibition (Bartos 
et al., 2001, Gibson et al., 1999, Galarreta and Hestrin, 1999a). This inhibition 
influences rhythmic synchrony and facilitates information processing during cognitive 
tasks. They are involved in both feedforward and feedback inhibition (figure 3) (Pouille 
and Scanziani, 2001, Buzsàki and Eidelberg, 1981, Pouille and Scanziani, 2004). 
Feedforward inhibition is regulated primarily by fast-spiking PV+ cells, because these 
interneurons fire early after stimulation, before pyramidal cells and regularly spiking 
interneurons (Pouille et al., 2009).  
 
FIGURE 3: MORPHOLOGY OF PV+ INTERNEURONS AND MECHANISMS OF 
INHIBITION. A| Morphology of a PV+ basket or chandelier cell. Both types have multiple 
dendrites (black) that often cross layers. Axons (ax, grey) show extensive arborisation. Ch – 
terminal portion of the axon, which forms a short vertical row of boutons resembling 
candlesticks. Each Ch terminal innervates a single initial segment of a pyramidal cell (DeFelipe, 
1999). Basket cell adapted from http://www.people.vcu.edu/~amcquiston/photogallery. B| Feed-
forward inhibition dampens (“filters“) the effect of afferent excitation. The interneuron (grey 
circle) is activated by upstream pyramidal cells, which results in a decreased activity of the 
downstream principal cell (black triangle). C| Increased firing of the principal cell elevates the 
discharge frequency of the interneuron. This may decrease the principal cell output, providing a 
regulatory mechanism by limiting the own activity. B and C adapted from (Buzsaki and Jonas, 
2007). 
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Feedback inhibition implements the “winner takes all” network mechanism: principal 
cells with the strongest input fire and action potential initiation in the remaining cells are 
inhibited. Feedback inhibition, both recurrent and lateral, has been demonstrated to 
rely on the activation of PV+ interneurons. (Pouille and Scanziani, 2004, de Almeida et 
al., 2009b, de Almeida et al., 2009a). 
Several optogenetic manipulations of PV+ interneuron activity showed that they are 
necessary and sufficient for the generation of network oscillations in both the 
hippocampus and neocortex. Activation of PV+ cells at theta frequency (4-10 Hz) 
triggers theta spike resonance in CA1 pyramidal cells (Stark et al., 2013), and 
stimulation of PV+ cells at gamma frequency (32-100 Hz) induced gamma oscillations 
in the local field potential in the somatosensory cortex (Cardin et al., 2009, Sohal et al., 
2009). This major role of PV+ interneurons for network oscillations, which are the 
hallmark of neuronal network function in several brain areas, determines the role of 
PV+ interneurons for complex animal behaviour (Murray et al., 2011, Fuchs et al., 2007, 
Korotkova et al., 2010). 
Additionally to this diverse population of inhibitory PV+ interneurons a small subgroup 
of excitatory PV+ interneurons are distributed throughout the brain (Markram et al., 
2004). In 2015 an excitatory PV+ visual pathway from the superior colliculus (SC) to the 
parabigeminal nucleus (PBGN) and amygdala has been identified which triggers fear 
responses, induces conditioned aversion, and causes depression-related behaviour 
(Shang et al., 2015). Moreover, the majority of PV+ corticostriatal projection neurons 
are glutamatergic (Lewis et al., 2001, Jinno and Kosaka, 2004).  
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GABAERGIC SIGNALLING 
GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter in the mature 
mammalian central nervous system and thereby the main regulator of excitation via 
inhibition. In inhibitory synapses, GABA is synthesised from glutamate by the enzyme 
glutamate decarboxylase (GAD) and stored in vesicles until released. If interneurons in 
the adult brain are activated by upstream excitatory neurons, the resulting action 
potentials lead to activation of signalling cascades leading to GABA release into the 
synaptic cleft. At the synapse GABA will activate GABA receptors, either the fast 
ionotropic chloride ion-selective GABAA receptors or the metabotropic G-protein 
coupled GABAB receptors. A third class of GABA receptor, the GABAC receptor, is 
found predominantly in the vertebrate retina (Bormann and Feigenspan, 1995). The 
three classes differ in localisation, electrophysiological, biochemical and 
pharmacological properties. 
GABAA RECEPTOR (GABAAR) 
The GABAA receptor, which is the principal mediator of synaptic inhibition, belongs to 
the superfamily of Cys-loop receptors and is a hetero-oligomeric protein that consists of 
five membrane spanning subunits around a central pore (figure 4A) (Campagna-Slater 
and Weaver, 2007). At least 19 mammalian genes encode for different GABAA receptor 
subunits (α1–6, β1–3, γ1–3, δ, ε, φ, π and ρ1–3) with additional diversity arising from 
alternative splicing (Macdonald and Olsen, 1994). The individual subunits exhibit 
specific expression patterns in certain brain regions, and a distinct subcellular 
localisation (Korpi et al., 2002, McKernan and Whiting, 1996). However, most 
 
 
10 
 
GABAARs are composed of two α subunits, two β subunits and one other (γ, δ, ε, φ, or 
π ) subunit (Rudolph and Mohler, 2004). In addition, receptors with different subunit 
compositions mediate primarily synaptic or primarily extrasynaptic signalling (figure 4B) 
in dependence of the respective subcellular localisation. 
 
 
FIGURE 4: COMPOSITION OF GABAAR. A| Five subunits from seven subunit subfamilies 
(α, β, γ, δ, ε, φ, π) form a heteropentameric channel that is permeable for Clˉ and HCO3ˉ. 
Binding of the neurotransmitter GABA occurs at the interface between the α and β subunits and 
triggers the opening of the channel, allowing the rapid flux of Clˉ and HCO3ˉ. Benzodiazepines 
(BZ) bind at the interface between α (1, 2, 3 or 5) and γ subunits and potentiate GABA-induced 
Clˉ flux. B| GABAARs composed of α (1–3) subunits together with β and γ subunits primarily 
localise synaptically, whereas α5βγ and α(4 or 6)βδ receptors are located largely at 
extrasynaptic sites. Modified from (Jacob et al., 2008). 
 
Upon binding of GABA, allosteric movements in the channel result in an opening of the 
ion pore allowing Cl¯ and bicarbonate (HCO3ˉ) ions to cross the membrane (Bormann et 
al., 1987, Kash et al., 2004, Kaila, 1994). The direction of the ion flow, inward or 
outward, depends on the electrochemical gradient of distribution of these two anions 
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across the plasma membrane and the membrane potential of the cell. In mature 
neurons the chloride equilibrium potential (EClˉ) is more negative than the resting 
membrane potential (Vm). The equilibrium potential for bicarbonate is more positive 
than Vm, but KCC2 is much less permeable for bicarbonate than for chloride. 
Therefore, activation of GABAA receptors mediates a net inward flow of anions and a 
hyperpolarising postsynaptic response - the inhibitory postsynaptic potential (IPSP). 
This leads to a reduction in the probability of action potential generation, causing 
neuronal inhibition (Cherubini, 2012). 
Afterwards, GABA diffuses in the extracellular space before being taken up by selective 
plasma membrane transporters, which regulate the clearance of the neurotransmitter 
and shape synaptic currents (Cherubini and Conti, 2001). 
GABAERGIC INHIBITION 
The short-lasting inhibition, called phasic inhibition, typically generated by synaptic 
GABAAR activation following action potentials in a presynaptic interneurons is just one 
mechanism of inhibition (Cherubini, 2012).  
Additionally, spill over of GABA in the extracellular space can stimulate molecularly and 
functionally specialised GABAA receptors that localise extrasynaptically and have a 
higher affinity to GABA (Farrant and Nusser, 2005), a process termed tonic inhibition. 
Moreover, they are more resistant to desensitisation and submicromolar concentrations 
of ambient GABA lead to a permanent increased membrane conductance, dampening 
the voltage change of synaptic input (Farrant and Kaila, 2007, Glykys and Mody, 2007). 
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Opening the chloride channel not only allows free flow of chloride ions across the 
membrane but also reduces the transmembrane resistance. If EClˉ equals Vm, no net 
ion flow occurs through an open GABAAR. Due to the channel opening the membrane 
conductance increases and the membrane resistance falls. According to Ohm’s law 
(V=I*R) the smaller membrane resistance causes a decrease of voltage (Mitchell and 
Silver, 2003) and thereby inhibits the neuron via reduction of excitatory currents. These 
reduced excitatory currents diminish the excitatory postsynaptic potentials (EPSP) 
locally. This process is termed shunting inhibition and effectively suppresses excitation 
from distal sources that must pass through that region on the way to the soma, 
whereas it has less influence on proximal EPSPs that influence the soma directly 
(Paulus and Rothwell, 2016). 
Since this effect also takes place simultaneously with ‘classical’ hyperpolarising 
inhibition, the result is a dual inhibitory effect on ongoing excitatory inputs (Furman, 
1965). 
GABAERGIC EXCITATION 
In embryonic neurons the intracellular Clˉ concentration [Clˉ]i is around 25mM due to a 
different ion channel expression pattern than in adult neurons (Ben-Ari, 2002). This 
shifts EClˉ from more negative than Vm to more positive than Vm, causing efflux of Clˉ 
across GABAAR channels and thus GABA-mediated depolarisation. The depolarizing 
action of GABA in immature neurons can generate action potentials by activating 
voltage-gated sodium channels, promote glutamate signalling by removing the 
magnesium block of N-methyl-D-aspartate receptors (NMDARs), and increase 
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intracellular Ca2+ by activating voltage-gated calcium channels. In addition, the 
depolarising response may be enhanced non-synaptically by the extracellular 
accumulation of potassium (K+) ions (Kaila et al., 1997, Smirnov et al., 1999). Through 
these mechanisms, depolarising GABA promotes synchronous network oscillations and 
modulates activity-dependent processes such as neuronal maturation and 
synaptogenesis (Ben-Ari, 2002). Essential to switch from depolarising to 
hyperpolarising seems to be the change of Clˉ ion transporter expression, with sodium-
potassium-chloride cotransporter 1 (NKCC1) and potassium-chloride cotransporter 2 
(KCC2) being the most important. 
Besides the role in development, the role of GABAergic excitation in mature neuronal 
function, network regulation and disease has been discussed intensively (Avoli and de 
Curtis, 2011, Ben-Ari et al., 2012, Cherubini and Conti, 2001, Cossart et al., 2005, 
Ellender et al., 2014, MacKenzie and Maguire, 2015, Nabekura et al., 2002, Staley et 
al., 1995, Staley and Mody, 1992, Viitanen et al., 2010, van den Pol et al., 1996, 
Chavas and Marty, 2003). There is growing evidence that GABAergic depolarisation 
occurs naturally and functionally in the CNS of adult animals. In some brain regions, 
GABA acts both excitatory and inhibitory (Wagner et al., 1997, Bazhenov et al., 1999, 
Chavas and Marty, 2003), suggesting that dynamic excitatory GABAergic transmission 
plays a critical role in controlling normal brain function. Interestingly, excitatory GABA 
actions have also been reported in seizure generation (Cohen et al., 2002, Fujiwara-
Tsukamoto et al., 2003, Ben-Ari et al., 2012). 
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CATION-CHLORIDE COTRANSPORTERS (CCCS) 
Electroneutral chloride transporters are often referred to as cation-chloride 
cotransporters (CCCs) and belong to the superfamily of solute carrier transporters 
(SLC). These transporters can be subdivided into four groups with (1) the NKCC 
symporters which transport sodium (Na+), K+ and Cl¯, (2) the NCC symporters, which 
move Na+ and Cl¯, (3) the KCC cotransporter which carries K+ and Cl¯ and (4) Cl¯-
cation cotransporters (Knoflach et al., 2016). These latter transporters have a structure 
with 12 putative transmembrane domains with both the N- and C-termini facing the 
intracellular compartment. They are thought to form dimers in the membrane allowing 
the formation of the anion–cation binding pocket enabling the translocation of ions. As 
symporters, they cover the energy requirements passively from transmembrane 
differences in ion concentrations. The CCCs utilize the K+ or Na+ gradients built up by 
the Na+/K+-ATPase to translocate Cl¯ across the membrane. NKCC1 and KCC2, two 
members of SLC12 family, are known to have cell-autonomous functions in central 
neurons especially in creating the reversal potential and driving force of anion currents 
utilised by GABAARs and glycin receptors (GlyRs) (Blaesse et al., 2009). 
NKCC1 
Na+-K+-Clˉ cotransporters (NKCC) belong to the cation dependent chloride 
cotransporter family (CCCs; figure 5) and mediate the transport of Na+, K+ and Clˉ ions 
into the cell. 
The Na+-K+-Clˉ cotransporter 1 (NKCC1), encoded by the gene Slc12A2, is widely 
expressed in different tissues and cell types. 
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Two alternative splicing variants have been reported in humans and mice (Vibat et al., 
2001, Bailey et al., 2013), NKCC1a and NKCC1b. In mice Nkcc1b lacks exon 21, which 
encodes a 16-amino acid peptide located in the COOH-terminal tail of the protein. The 
absence of this exon causes the loss of the single protein kinase A (PKA) consensus 
site of the cotransport protein (Bailey et al., 2013). In neurons the NKCC1 mediated 
flux of ions is directed inward, creating a high Clˉ ion concentration. 
Even though it has been shown by several studies that NKCC1 is important for 
establishing the Cl¯ concentration in neurons, it is controversially discussed whether a 
decreased expression of NKCC1 is responsible for the switch from high to low Clˉ in 
adult neurons (figure 6B) (Dzhala et al., 2005, Zhang et al., 2007). While some studies 
suggest a postnatal downregulation of NKCC1 (Dzhala et al., 2005, Liu and Wong-
Riley, 2012, Hübner et al., 2001a), others indicate an upregulation of NKCC1 
expression in the CNS during development (Mikawa et al., 2002, Hyde et al., 2011, 
FIGURE 5: THE SLC12A GENE FAMILY. 
Cluster dendrogram of human Slc12a 
cotransporters. The two major branches of 
cation-chloride cotransporters (CCC) separated 
early during evolution. The functionally not yet 
characterized CCC9 separated early from the 
Na+-dependent branch of cation-Clˉ 
cotransporters. In a similar fashion, CCC8 
separated early from Na+-independent K+-Clˉ 
cotransporters. The length of tree branches can 
be compared with the reference bar, which 
represents 0.1 amino acid substitutions per site. 
Adapted from (Gagnon and Delpire, 2013). 
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Morita et al., 2014). In 2009 Blaesse et al. concluded that the use of antibodies and 
probes insensitive to NKCC1b, the splice variant that constitutes up to ∼80 % of the 
total NKCC1 transcript in the human CNS (Vibat et al., 2001) confounds those results. 
On the basis of microarray data analysis with probes spanning both major human 
NKCC1 splice variants NKCC1a and NKCC1b (Vibat et al., 2001, Morita et al., 2014), 
Sedmak et al. found that NKCC1 expression in all of the examined human brain 
regions undergoes developmental upregulation (Sedmak et al., 2015).  
NKCC1 is kinetically regulated through a Clˉ-sensing cascade involving with no lysine 
kinase (WNK), STE20-related proline/alanine-rich kinase (SPAK) and oxidative stress–
responsive kinase 1 (OSR1). SPAK-mediated phosphorylation of key N-terminal 
threonine residues (for example, T212 and T217) of NKCC1 results in its activation and 
Clˉ accumulation. In contrast, dephosphorylation of these residues by protein 
phosphatase 1 (PP1) inactivates NKCC1 (figure 6A). Reciprocal regulation of transport 
activities of NKCC1 and KCC2 by the WNK–SPAK and WNK–OSR1 cascade has been 
demonstrated in heterologous expression systems and may also take place in neurons 
(Medina et al., 2014). 
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FIGURE 6: NKCC1 AND KCC2. AI Secondary structures of human KCC2b and NKCC1b 
splice isoforms. KCC2: Dephosphorylation sites at threonine T906 and T1007 and 
phosphorylation at serine S940 are associated with functional activation. Phosphorylation by 
protein kinase C (PKC) at S940 promotes membrane stability. An arginine-to-histidine mutation 
at residue 952 (R952H) results in loss of both transport activity and spinogenesis. NKCC1: 
Phosphorylation of NKCC1 by SPAK and OSR1 at the depicted N-terminal residues leads to 
functional activation. Dephosphorylation of NKCC1 by PP1 at threonine residues renders it 
transport-deficient. Putative glycosylation sites in KCC2 and NKCC1 are highlighted. Adapted 
from Kaila et al 2014. BI Regulation of intracellular chloride concentration by NKCC1 and KCC2. 
In immature neurons NKCC1 dominates over KCC2 expression resulting in high intracellular 
chloride concentrations of around 25 mM. Activation of GABAA results in outward directed Cl- 
flow and depolarization. In adult neurons KCC2 expression increases and [Clˉ-]i is lowered to 7 
mM. Opening of GABAA receptor leads to Cl- influx and hyperpolarization. Epilepsy/trauma may 
reverse the channel composition. 
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KCC2 
The neuron-type and brain region-specific expression patterns of KCC2 have been 
studied extensively in different species (Kaila et al., 2014a). In mammals, the sodium-
potassium cotransporter 2 (KCC2), encoded by the gene SLC12A5, is abundantly 
expressed in neuronal cells, with very little or no expression in peripheral neurons, 
neuronal progenitors, and non-neuronal cell types, including glia (Blaesse et al., 2009, 
Gagnon et al., 2013, Kanaka et al., 2001). KCC2 is located in the plasma membrane of 
somata and dendrites of neurons throughout the CNS including all layers of the cortex, 
neurons of the brainstem, thalamus, olfactory bulb, and spinal cord, CA1–CA4 
pyramidal neurons of the hippocampus, granular layer, and Purkinje neurons (Payne et 
al., 1996, Uvarov et al., 2007). The CNS neuron specific expression depends on 
various mechanisms, including binding sites for neuron-enriched transcription factors 
such as Egr4 and neuron-restrictive silencing elements (Uvarov et al., 2006, Uvarov et 
al., 2005). 
Alternative splicing of the Kcc2 gene results in two Kcc2 isoforms, Kcc2a and Kcc2b. 
They differ in 40 amino acids in the N terminus encoded by an alternatively spliced 
exon (called exon 1a and 1b). Kcc2a contributes 20–50 % of the total Kcc2 mRNA 
expression in the neonatal mouse brain stem and spinal cord but only 5–10 % in the 
mature cortex. During postnatal development, the KCC2a expression remains relatively 
constant whereas Kcc2b expression increases and prevails. Since mice that lack only 
KCC2b but retain an apparently normal level of KCC2a expression survive for up to 2 
weeks, absence of KCC2b is presumably sufficient to support vital neuronal functions 
in the brain stem and spinal cord but not in the cortex (Uvarov et al., 2007). Mice 
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lacking both KCC2 isoforms die immediately after birth due to severe motor defects, 
including respiration failure (Hübner et al., 2001b). Since the investigated mouse model 
affects both isoforms in what is discussed below, ‘‘KCC2’’ will refer to both splice 
variants. 
The already mentioned upregulation of KCC2 expression seems to be part of neuronal 
differentiation and maturation. It takes place around time of birth and is both brain 
region- and species-specific. Cortical neurons of new born rats show very low KCC2 
expression with depolarizing GABAAR-mediated responses, whereas cortical neurons 
of the guinea pig increase KCC2 expression in utero and show hyperpolarising 
GABAAR responses at birth (Rivera et al., 1999). In human cortical neurons KCC2 
expression was detected from the 25th postconceptional week onwards indicating that, 
unlike in rodents, upregulation of KCC2 begins prenatally (Robinson et al., 2010, 
Sedmak et al., 2015). 
ROLE OF KCC2 IN MORPHOLOGY OF NEURONS 
In addition to the ion transport function of KCC2, it has been reported to be essential 
for spine formation in excitatory neurons. Essential for this shaping function seems to 
be the interaction of the KCC2 C-terminus with the cytoskeleton-associated protein 
4.1N (figure 7) (Chamma et al., 2012). 4.1N possesses a 4.1 Ezrin Radixin Moesin 
(FERM) domain that binds a variety of transmembrane proteins and a spectrin/actin 
interaction domain (Baines et al., 2009). Therefore, KCC2 is expected to interact with 
the sub-membrane actin cytoskeleton. Such interactions may have multiple 
implications like e.g. (1) regulation of KCC2 clustering and thereby its membrane 
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stability/activity, (2) restriction of KCC2 localisation to specific membrane domains, (3) 
control of the local organisation of actin filaments with effects on subcellular 
morphology of synapses (Li et al., 2007, Mohandas et al., 1992, Cancedda et al., 2007, 
Gauvain et al., 2011), and (4) regulation of cell migration (Wei et al., 2011) (Mills et al., 
1994). 
 
FIGURE 7: KCC2 LOCALISATION AT DENDRITIC SPINES. KCC2 interacts with the 
cytoskeleton-associated protein 4.1N and thereby regulates correct AMPA receptor localization 
at glutamatergic synapses (Gauvain et al., 2011). GABAergic synapses do not form on spines, 
but on dendrites. Here ion transport function of KCC2 is important for polarity of GABAergic 
currents (Chamma et al., 2012). 
 
REGULATION OF KCC2 EXPRESSION 
Many signalling molecules are important in controlling KCC2 function. Brain derived 
neurotrophic factor (BDNF), Insulin-like growth factor 1 (IGF-1) and Neurturin (NRTN, 
which belongs to the glial cell-line derived neurotrophic factor (GDNF) family of 
neurotrophic factors) have been identified as efficient modulators of the expression 
(Rivera et al., 2004), but only the regulatory effects of BDNF are well characterized. By 
binding to its receptor tropomyosin-related kinase B (TrkB), BDNF promotes the up-
regulation of KCC2 expression by activating extracellular signal-regulated kinase 1/2 
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(ERK1/2)-dependent expression of Early Growth Response Protein 4 (EGR4) (Uvarov 
et al., 2006). Additionally the transcription is controlled by upstream stimulating factors 
1 (USF1) and 2 (USF2) (Markkanen et al. (2008) and steroid hormones (Galanopoulou, 
2008, Kight and McCarthy, 2014). Fast functional regulation of CCCs is mediated by 
post translational mechanisms, including phosphorylation of key residues in the 
intracellular domains and calpain-mediated cleavage (figure 5A) (Puskarjov et al., 
2012). Phosphorylation of C-terminal serine residue S940 by protein kinase C (PKC) 
limits clathrin-mediated endocytosis of KCC2 and PP1-dependent dephosphorylation of 
S940 leads to internalisation of KCC2 and a reduction in neuronal Clˉ extrusion 
capacity. Intense activation of N-methyl-D-aspartate receptors (NMDARs) and the 
consequent 
 increase in [Ca2+]i also induce cleavage of KCC2 C-terminally by the Ca2+- and BDNF-
activated protease calpain, which results in irreversible inactivation of KCC2 (Zhou et 
al., 2012). KCC2 activity is limited by phosphorylation of two C-terminal threonines, 
Thr(906) and Thr(1007), which depends on WNK1 and downstream SPAK/OSR1 
(Friedel et al., 2015, Inoue et al., 2012). 
PRELIMINARY WORK 
The importance of KCC2 in chloride homeostasis and inhibition has been investigated 
in many studies and constitutive and conditional knockout mouse models for KCC2 are 
well established. Our lab created a constitutive knockout model for total KCC2 that dies 
immediately after birth due to severe motor deficits that also impair respiration (Hübner 
et al., 2001b) and a conditional knockout mouse model (Seja et al., 2012). Notably the 
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specific disruption of Kcc2 in cerebellar granule cells (GCs) and Purkinje cells (PCs), 
did not change synapse density nor spine morphology, but increased [EClˉ]i roughly two-
fold and nearly abolished GABA-induced hyperpolarization in PCs. Interestingly, these 
mice did not show an obvious motoric phenotype, but deficits in motor learning.  
To study the role of KCC2 in interneurons and the subsequent effects to the neuronal 
network, KCC2 has been deleted in the largest subpopulation of interneurons by 
crossing the conditional KCC2 knockout mouse with a PV+ - Cre line. The resulting 
knockout animals show a severe phenotype with decreased weight (figure 8A), motor 
deficits, a shortened life span (figure 8B) and spontaneous epilepsy.  
 
FIGURE 8: SURVIVAL AND DEVELOPMENT OF WEIGHT IN PV+-KCC2 
KNOCKOUT MICE. A| Kaplan-Meier survival curve of wild type (WT), heterozygous knockout 
(HET) and homozygous knockout (KO) mice. KO animals present a shortened life span with an 
average life time of 94 days (Mantel-Cox-Test p < 0,0001). B| Weight development of KCC2 
mice. WT and HET mice show a normal development whereas PV-KO animals demonstrate a 
decrease of body weight (two-way ANOVA p < 0,0001). Unpublished data from Ralf Dittmann. 
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AIM OF THE STUDY 
During the last decades, the published data more and more suggest a dynamic role of 
GABAergic inhibition in early brain development and microcircuit formation. Since the 
GABA response critically depends on chloride gradients, which are mainly established 
via cation chloride cotransporters KCC2 and NKCC1, the latter have been the focus of 
many studies. However, because of the high diversity of interneurons, their role in 
interneurons has not been properly addressed so far. Our aim was to study whether 
KCC2 plays a role for the regulation of the parvalbuminergic interneurons and their 
activity. To address, how changes in chloride concentrations of PV+ interneurons affect 
network excitability and brain function we disrupted Kcc2 in parvalbuminergic 
interneurons.  
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MATERIAL AND METHODS 
MICE 
The mice were bread and housed in our animal facility. All experiments were officially 
approved by the Thüringer Landesamt für Lebensmittelsicherheit und 
Verbraucherschutz (Tierversuchsantrag Reg.-Nr. 22-2684-04-02-066/11). 
The two mouse strains involved in this study are conditional KCC2 knock out mouse 
models that lack KCC2 expression in parvalbuminergic neurons. Both express a Kcc2 
allele with exons 2-5 flanked by loxP sites (described in (Seja et al., 2012); figure 9A) 
resulting in a non-functional protein if recombined by Cre recombinase. Those mice 
were bread with B6;129P2-Pvalbtm1(cre)Arbr/J mice that express the Cre recombinase 
under the parvalbumin promoter (Hippenmeyer et al., 2005) (PVcre+, 9B), leading to a 
specific knock out of KCC2 in parvalbuminergic cells. The specificity of this Cre line 
was proven by Ralf Dittmann. For all experiments, mice with the following genotypes 
were used: (WT) = KCC2flox/flox, PVcre-; (HET) = KCC2flox/+, PVcre+ and (KO) = 
KCC2flox/flox, PVcre+. 
For the second mouse line the described mice were bread with B6.Cg-
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J reporter mice (figure 9C) that express tdTomato if 
activated by Cre recombinase (Madisen et al., 2010). In our mouse model this results 
in fluorescent dye labelled parvalbuminergic cells with the following genotypes: 
homozygous knockout (KO) = KCC2flox/flox resepctively wildtype (WT) = KCC2+/+, 
PVcre+, tdTomatoflox/flox and heterozygous KO (HET) = KCC2flox/+, PVcre+, 
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tdTomatoflox/flox. WT animals had to be PV cre+ to induce tdTomato expression and 
therefore only animals with two wildtype Kcc2 alleles (KCC2+/+) were suitable as 
controls. 
 
FIGURE 9: GENETIC MODIFICATIONS OF MICE. A| Strategy for generation of cell type 
specific KCC2 knockout mice. Exons 2–5 were flanked by loxP sites, which are recognised by 
Cre recombinase. B| PV genomic locus. Expression of Cre was realised by integration of an 
IRES-Cre cassette 3′ to the translational stop codon of PV. C| Schematic diagram of the gene 
targeting strategy with a Cre reporter cassette inserted into the Rosa26 locus into intron 1. The 
construct contains a strong and ubiquitously expressed CAG promoter and the loxP-flanked 
('floxed') stop cassette–controlled tdTomato gene. The woodchuck hepatitis virus 
posttranscriptional regulatory element (WPRE) was added to enhance mRNA transcript stability 
(Madisen et al., 2010). Grey arrowheads mark the loxP sites and red arrows mark the primer 
binding sites. 
GENOTYPING 
For genotyping of mice, the DNA was isolated from tail biopsies by adding alkaline lysis 
buffer (25 mM NaOH, 0.2 mM EDTA; 30 min; 95°C) and the reaction was neutralized 
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using 40 mM Tris-HCl for 2 min at 4°C. The DNA was stored at 4°C until used for 
genotyping by polymerase chain reaction (PCR). 
Therefore, a PCR reaction master mix (20 µl) with 14.6 µl ddH2O, 2 µl reaction buffer 
(10x), 0.8 µl MgCl2, 0.5 µl dNTP-Mix (dATP, dCTP, dGTP, dTTP 8 mM), 0.5 µl sense 
primer (100 nM, table 1), 0.5 µl antisense primer (100 nM, table 1), 0.08 µl Taq-
Polymerase (Invitrogen) was prepared, added to 1.5 µl DNA and then placed into a 
thermo cycler (T3000, Biometra). The primers for genotyping were designed by 
screening of the MGI-data base (http://www.informatics.jax.org/), NCBI-data base 
(http://www.ncbi.nlm.nih.gov) and with the online tool of LabLife 
(https://www.lablife.org/ll). Specificity was verified with „Primer-Blast” 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast). PCR programs were set up according 
to the melting temperatures of primers. 
Primer Sequence (5’-3’) 
Kcc2 loxP forward TCT GCC TGG AAC ACT CTC CTG C 
Kcc2 loxP reverse CAA CCT GAA CTC CCA AGG ATA CC 
mKA1 forw AAC AGC GAG CCC GAG TAG TG 
mKA1 rev TAA GAA CTA GAC CCA GGG TAC AAT G 
Cre forw AAA CGT TGA TGC CGG TGA ACG TGC 
Cre rev TAA CAT TCT CCC ACC GTC AGT ACG 
tdTomato wt forw  AAG GGA GCT GCA GTG GAG TA 
tdTomato wt rev CCG AAA ATC TGT GGG AAG TC 
tdTomato mutant rev GGC ATT AAA GCA GCG TAT CC 
tdTomato mutant forw CTG TTC CTG TAC GGC ATG G 
TABLE 1: PRIMER FOR GENOTYPING.  
Horizontal gel electrophoresis (2 % agarose in running buffer, containing 40 mM Tris, 
0.11 % acetic acid and 1 mM EDTA) was done to separate PCR products. DNA 
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fragments were visualised by addition of ethidium bromide to the gel (0.05 ng/ml). 
Samples with loading dye (25 % ficoll 400, 100 mM EDTA, 0.25 % bromphenolblue) 
and gels were loaded in tris acetate EDTA buffer. Fragment sizes were determined by 
comparison with bands of a 100kb-ladder (Gene graft). Depending on the expected 
fragment sizes, bands were separated at a constant voltage of 120 V for 30-60 min and 
evaluated under ultraviolet light. Genotyping for KCC2 resulted in a 490 bp band for 
floxed Kcc2-allels or a 291 bp band for WT Kcc2-alleles. Genotyping for PV showed a 
388 bp band for the internal control gene KA1 and a 214 bp band for Cre. The 
tdTomato PCR resulted in a wildtype band of 297 bp and a mutant band of 196 bp.  
IMMUNOHISTOCHEMISTRY 
To obtain brain sections for staining mice were anesthetised (67 % v/v NaCl-Lösung 
0.9 %, 28 % w/v Ketamin, 0.17 % v/v Rompun) via intraperitoneal injection of 
anaesthesia (ketamine 80 mg/kg bodyweight, xylazin 10 mg/kg bodyweight). To assure 
effective anesthesia the mice were pinched in the foot several times painfully with 
forceps to trigger nociceptive reflexes. When no reflexes could be observed after 
painful stimulation, the mice were placed on a preparation surface and transcardially 
perfused with phosphate buffered saline (PBS: pH 7.4, 140 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 1.8 mM KH2HPO4) and 4 % paraformaldehyde in PBS (PFA: 20 g 
paraformaldehyde in 500 ml PBS, filtered, pH 7.4). The ventral skin was cut with 
scissors, just below the xiphoid process. The ventral skin opening was expanded by 
manually pulling the opposing skin segments rostrally and caudally. Thoracic and 
peritoneal muscles and muscle fasciae were exposed, cut with scissors, just below the 
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xiphoid process and the diaphragm and visceral organs were exposed. The thoracic 
cavity was opened by cutting the diaphragm and both lateral aspects of the rib cage. 
Using blunt forceps, the right ventricular free-wall of the heart was gently grasped and 
a hypodermic needle (0.40x20 mm, B.Braun) was carefully inserted in the brighter 
coloured left ventricle. After opening of right atrial-chamber with scissors, the blood was 
removed by perfusion with saline for 5 min (flow 2-3 ml/min). Fixation was performed 
with 4 % PFA for 10 min (flow 2-3 ml/min). Brains were removed and further 
processed. 
QUANTIFICATION 
Quantifications of PV+ interneurons in cortices and in hippocampi of WT, HET and KO 
mice were performed at the age of 4 weeks, 8 weeks and 23 weeks as previously 
described (Gerstmann et al., 2015). The dissected brain was post fixed in 4 % PFA 
over night at 4°C and afterwards incubated in sucrose (15 % and 30 % consecutively) 
for cryoprotection. For free-floating stainings cryosections (40µm) were cut with a 
sliding microtome (Leica) and stored in anti-freezing medium (150 g glucose, 300 ml 
ethylenglycol, 200 mg sodium acid, 0.24 ml NaH2PO4 x H2O, 0.425 ml Na2HPO2 
anhydr., filled up to 1000 ml with aqua dest.) at -20°C.  
After three times washing with PBS for 5 min, the slices were permeabilised in PBS-T 
(PBS with 0.25 % Triton X-100, Sigma-Aldrich) for 20 min at room temperature, 
incubated for 1 hour in blocking solution (PBS with 0.25 % Triton X-100 and 5 % goat 
serum, Millipore) to avoid unspecific staining and transferred to wells containing 
primary antibodies diluted in blocking solution overnight at 4°C. The primary antibodies 
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were diluted as indicated in table 2. After three times washing with PBS for 5 min, the 
slices were incubated in secondary antibodies diluted in blocking solution (table 2) for 3 
hours at room temperature. Washing with PBS was followed by incubation with 4',6-
diamidino-2-phenylindole (DAPI; 1 µg/mL; Sigma-Aldrich) for 5 min, another wash step 
and mounting of slices to glass slides (HistoBond® adhesive microscope slides, 
Marienfeld) with a brush. Fluoromount® (Calbiochem) was applied with a Pasteur 
pipette for mounting. Cover slips (Marienfeld) were fixed to the slides by transparent 
nail polish (p2 cosmetics). Until analysis by confocal laser microscopy (TCS SP5, 
Leica) or Cell Observer (Carl Zeiss), slides were kept at 4°C. 
Antibody Company Dilution 
Mouse Anti-Parvalbumin Svant (235) 1:5000 
Rabbit anit-KCC2 Millipore (07-432) 1:1000 
Rabbit anti-GABA Sigma (A2052) 1:2000 
Alexa Fluor® 555 goat anti–mouse IgG Invitrogen (A21424) 1:2000 
Alexa Fluor® 488 goat anti–rabbit IgG Invitrogen (A11008) 1:2000 
TABLE 2: DILUTION OF PRIMARY AND SECONDARY ANTIBODIES 
 
Quantification of hippocampal PV+ interneurons was performed by counting of PV+ 
cells in the whole hippocampus of three consecutive slices (coronal, bregma -2.30, 
according to mouse brain atlas (Paxinos and Franklin, 2004)) at the cell observer.  
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To calculate the number in the cortex, images of somatosensory cortex were taken at 
the confocal laser-scanning microscope from the same slices used for quantification of 
hippocampal interneurons. The settings at the confocal laser-scanning microscope 
were optimized by taking the WT pictures first and then saved to be reused for all other 
pictures. The pictures were processed in ImageJ and cells were counted according to 
cortical layers. Therefore, the cortical regions of interest (ROI) were mapped in the 
DAPI channel, saved to the ROI manager and displayed in the parvalbumin channel 
(figure 10). The cells were counted in the different ROIs and cell number per 100000 
µm² was calculated: 
cell number per 100000 µm2  =  ሺcell number ROIሻ ROI area in µm2 * 100000 µm2 
 
  
FIGURE 10: QUANTIFICATION 
OF PV+ NEURONS. Coronal 
slices were taken at position - 2.30 
from the bregma and stained with 
anti-parvalbumin antibody (PV, red) 
and DAPI (blue). Identification and 
mapping of single cortical layers was 
accomplished in the DAPI channel of 
every image. Scale bar 75 µm. 
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MORPHOLOGY 
Acute brain slices (100 µm) from PV-tomato-KCC2 mice were cut at a vibratome (VT 
1000S, Leica Instruments), placed in 4 % PFA overnight and mounted on glass slides 
(HistoBond® adhesive microscope slides, Marienfeld, Germany) in Fluoromount® 
(Calbiochem) and stored at 4°C. Pictures were taken at the LSM and analysed with 
LAS AF Lite (Leica) and Axio Vision Rel4.8 (Zeiss) to identify possible changes in 
interneuron morphology.  
The number of dendrites emerging from the soma of investigated interneurons 
(referred to as basal dendrites) was counted by scrolling through the Z-Stacks and 
visualising the 3D structure of interneurons. The size of cell body was measured with 
the Axio Vision software. 
CORTICOSTERONE LEVEL 
ANIMAL HANDLING AND BLOOD PROCESSING 
To minimise stress, 10 days prior to blood collection the animals were housed in sets of 
two and handling of the mice was avoided. At the day of blood collection, the animals 
were placed in a quiet environment and left undisturbed. In a separate room, mice were 
rapidly decapitated and trunk blood collected 2 to 3 hours before the end of the light 
cycle, when the corticosterone (CORT) levels reach its peak (Atkinson and Waddell, 
1997). The blood was then centrifuged at 5000 rpm for 5 min; the serum was collected 
and stored at −80 °C until CORT analysis was performed. 
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ELISA 
Serum CORT was measured using an enzyme immunoassay kit (# 900-097; Enzo Life 
Sciences) according to the manufacturer’s instructions. The sensitivity of the assay was 
27 pg/ml; all samples were run in the same assay to avoid interassay variability. 
Sample size was 8–9 mice/group. The samples were diluted 1:40 in ELISA buffer and 
run in duplicates. Every plate included wells with negative controls (Blank, NSB), 
positive controls (Total Activity TA, Maximum binding Bo) and standards #1 - #5 (#1: 
20000 pg/mL; #2: 4000 pg/mL; #3: 800 pg/mL; #4: 160 pg/mL; #5 32 pg/mL). The 
ELISA plate reader was normalised against the Blank wells and optical density read at 
405 nm, with correction at 580 nm.  
Average net Optical Density (OD) bound for each standard and sample was calculated 
by subtracting the average NSB OD from the average OD bound: 
Average net OD = average bound OD – average NSB OD. 
The binding was calculated as a percentage of the maximum binding wells (Bo): 
Percent bound = net OD / net Bo OD * 100. 
Plotting a graph with the standard absorbance value as the dependent variable (Y-axis) 
and CORT concentration as the independent variable (X-axis) results in a standard 
curve. The standard curve was fitted with the exponential regression function: 
y = a*x2 + b*x + c. 
Solving for x determines the protein concentration of the sample.  
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ELECTROPHYSIOLOGY 
SLICE PREPARATION 
After decapitation of mice (8-10 weeks or 23 weeks of age) the brain was quickly 
removed, placed in ice cold artificial cerebrospinal fluid (aCSF: 120 mM NaCl, 3.5 mM 
KCl, 1.3 mM MgSO4 x 7 H2O, 12.5 mM NaH2PO4 x H2O, 2.5 mM CaCl2 x 2 H2O, 10 mM 
Glucose, 25 mM NaHCO3; bubbled with 5 % CO2, 95 % O2) and cut into coronal slices 
with a vibroslicer (VT 1000S, Leica Instruments) as described previously (Liebmann et 
al., 2009). Slices (350 μm) were stored at RT in aCSF for at least 1 hour until use. 
FIELD POTENTENTIAL RECORDINGS 
After equilibration, the slices were transferred to an interface-recording chamber. Slices 
were allowed to adapt onto recording conditions for 1 hour (oxygenated aCSF, 32°C, 
flow 2–3 mL/min). Bipolar stimulating electrodes with a tip diameter of 100 µm (SNE-
200X, Science-Products) were placed onto the glutamatergic Schaffer collaterals of the 
hippocampus CA3 region to stimulate CA1 pyramidal neurons. Upon stimulation (pulse 
duration 50 µs), field excitatory postsynaptic potentials (fEPSPs) were recorded using 
glass microelectrodes (2–5 MΩ, filled with aCSF) impaled into the stratum pyramidale 
or the stratum radiatum of hippocampal CA1 region. Slopes of fEPSPs and amplitudes 
of population spikes (PS) were analysed (figure 11). Data of field potential recordings 
were collected with an extracellular amplifier (EXT-02, NPI, Germany), low pass filtered 
at 4 kHz and digitally stored with a sample frequency of 10 kHz. Data acquisition and 
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analysis of population spike amplitudes were performed using the software Signal 
(Cambridge Electronic Design). 
To determine the maximal population spike amplitude or the maximal slope of fEPSP 
the stimulus intensity was increased in steps of 10 Volt (range 0-100 V) for each 
experiment (interstimulus interval 30 s). The relationship between stimulus intensity 
and the evoked response was fitted by a sigmoid function: R(i)=Rmax/1+exp(i–ih), where 
R(i) is the response at intensity (i), Rmax is the maximal response and ih is the intensity at 
which half-maximal response was observed. 
LONG-TERM POTENTIATION (LTP) 
For investigation of changes in LTP the following protocol was applied: Stimuli with 
half-maximal intensity were applied (interstimulus interval 20 s) for 30 min to record the 
baseline. The high frequency stimulus (HFS, 5 x 100 pulses a 100 Hz) induced 
increasing PS amplitudes and slopes of fEPSPs, which were recorded over 1 hour 
(interstimulus interval 20 s). The amount of potentiation was analysed by comparing 
baseline values (normalised and averaged 20 min before induction) with those values 
collected within 60 min after HFS application. 
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FIGURE 11: RECORDINGS OF FIELD POTENTIALS. A| Placement of electrodes for 
electrophysiological recordings in the hippocampus of acute coronal brain slices. The 
stimulation electrode is located in the stratum radiatum at the border of the CA2/3 area, while 
recording electrodes were placed in the stratum radiatum of the CA1. B| Exemplary baseline 
and post-HFS traces recorded from the stratum radiatum and the stratum pyramidale. 
 
FEPSP – TO – SPIKE COUPLING 
The fEPSP - to - spike ratio (also called E-S coupling) was recorded at the age of 8 and 
23 weeks. A stimulating electrode was placed into the stratum radiatum while recording 
electrodes were placed in the stratum radiatum and stratum pyramidale in the CA1 to 
measure fEPSPs generated by glutamatergic CA1 synapses between the fibres of 
Schaffer collaterals and CA1 pyramidal neurons and population spikes of CA1 neurons 
on the other hand, resulting from EPSP-driven action potential discharges. The 
stimulus intensity was increased in steps of 10 V (range 0-100 V) and the recorded 
slopes of fEPSPs with associated PS were grouped in the following classes: 0.5 
mV/ms, 1.0 mV/ms and 1.5 mV/ms 
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IN VIVO  EXPERIMENTS 
FEAR CONDITIONING 
Fear conditioning is a form of Pavlovian conditioning in which an initially neutral 
stimulus (conditioned stimulus; CS), usually a tone, is paired with the presentation of 
an aversive event (unconditioned stimulus; US), usually a footshock, to elicit fearful 
behaviour characterized by robust autonomic responses and a cessation of movement 
or freezing (Fanselow and Poulos, 2005, Smith et al., 2007). 
The experimental setup (Ugo Basile) consisted of 4 identical sound-attenuating 
chambers (d 55 x w 60 x h 57 cm) equipped with door switch, electrified grid floor, fan, 
camera, speaker, infrared and LED light. Animals were recorded the whole time for 
automatic detection of freezing by ANY-maze software (Stoelting). 
For delayed fear conditioning, a protocol was established similar as previously 
described (Langwieser et al., 2010, Kamprath and Wotjak, 2004). Adult animals (age 8-
13 weeks) were placed in the animal enclosure (d 17 x w 17 x h 25 cm) inside the 
chamber and allowed to explore the surrounding area for 180 s. A tone (CS) was 
played for the following 20 s (9 kHz, volume 20 %, 80 dB) paired with a foot shock (US, 
0.7 mA for 2 s) in the last 2 s administered via the metal grid. Mice remained in the 
chamber for additional 60 s after the shock before they were returned to their home 
cages. 
After 24 h, tone-shock association was analysed first. This was followed by test of 
context-shock association 2 h later. Animals were placed in a differently shaped animal 
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enclosure with altered colour (striped wall, white floor), lightening (2 lux), odour (3 % 
acetic acid) and fan speed (50 %). They were allowed to explore the new area for 180s 
before the conditioned stimulus (tone) was applied for 180 s. Mice remained in the 
chamber for additional 60 s before they were transferred back to their home cages. 
After 2 h they were placed in the same context as during acquisition (plexiglas walls, 
metal grid floor, lightening 5 lux, odour 70 % ethanol, fan speed 100 %) and observed 
for 180 s. 
For automatic freezing detection, the minimal freezing detection was set to 250 ms and 
the threshold (min: 33 a.u., max: 44 a.u.) defined. To verify the results of automatic 
detection all videos were assessed off-line from video tapes by an experienced 
observer who quantified the freezing response to the tone (Kamprath and Wotjak, 
2004). Freezing time was presented as percentage of the investigated 60 s intervals: 
freezing time ሺ%ሻ= ቆfreezing time ሺsሻ60 (s) ቇ *100 
 
To assess the increase in freezing time (Δtf (%)) induced by application of CS during 
the cued fear test, the change in freezing time was calculated as described: 
Δtf (%)= freezing pretone	ሺ%ሻfreezing time CS	ሺ%ሻ 
 
SEIZURE THRESHOLD 
To analyse the susceptibility to seizure inducing substances pentylentetrazole (PTZ) 
was injected (Sigma, 5 mg/ml in PBS) as described previously (Jacobs et al., 2008). 
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Therefore, the mice were weighed and the according amount of PTZ was calculated 
(60 mg per kg body weight). After injection, the mice were placed in a glass cylinder 
and the video camera was started. The latencies of the different stages (table 3) 
described as myoclonic jerks (focal seizure), clonic and tonic-clonic (generalized) 
seizures were analysed off-line. Onset of the epileptic seizure was defined by the 
following criteria: 
Phase Characteristic criteria 
myoclonic ear twitching, shaking 
clonic clonic seizures without loss of righting reflexes, clamping of the 
forefeet, rearing  
tonic-clonic loss of posture, tonic forelimb or hindlimb extrusion, generalized 
seizure 
TABLE 3: CRITERIA FOR SEIZURE PHASES 
 
STATISTICS 
Data are presented as mean ± standard error of mean (SEM). N defines the number of 
animals per experiment (biological replicate) and n defines the number of slices or cells 
(technical replicate) analysed. Statistical analysis was performed with GraphPad prism 
software. The unpaired, parametric two-tailed Student’s t-test was applied for results of 
experiments with two experimental groups. If more than two groups were compared, 
one-way analysis of variance (ANOVA) and subsequent Tukey’s test for post-hoc 
analysis were performed. In experiments, which included repeated measurements, 
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differences between groups were tested by repeated measures ANOVA. Two-way 
ANOVA was applied in a subset of experiments with subsequent Bonferroni’s multiple 
comparison tests. Significance was considered at p-values < 0.05 (* indicates p < 0.05; 
** indicates p < 0.01; *** indicates p < 0.001; **** indicates p < 0.0001). 
NOMENCLATURE 
The names of genes and proteins in this thesis are written according to the Mouse 
Genome Informatics Database (MGI) nomenclature 
(http://www.informatics.jax.org/mgihome/nomen/). The names are italicised when 
referring to the gene but nonitalic when referring to the protein.  
Symbols for human genes use all uppercase letters and symbols for mouse genes 
generally are written with only the first letter in uppercase and the remaining letters in 
lowercase.  
If referring to the protein, the symbols use all uppercase letters independent of the 
species.
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RESULTS 
GENERAL OBSERVATIONS 
Compared to WT the PV+-KCC2 KO mice showed an abnormal gait starting around 6-8 
weeks of age, which progresses over time. Their hind limbs appear spastic and an 
abnormal spreading of the legs was observed, when lifted up. HET animals could not 
be distinguished from WT.  
The difficulties to move properly also affected food uptake, since the KO animals were 
not able to climb to the food at the top of the cage. After onset of the described 
phenotype, the food was placed into the cage. Additionally; the bodyweight of KO mice 
was slightly reduced. 
Spontaneous seizures in KO animals were the most striking observation. The seizures 
were described by animal caretakers and emerged around 15 and 20 weeks of age. 
The age of onset was not quantified. 
MEMORY AND STRESS 
LTP 
LTP is considered as an  electrophysiological correlate of learning and since PV-KCC2 
KO  mice showed a decreased memory in the Morris water maze (Herrmann, 2015) 
long term plasticity was analysed in the stratum radiatum and stratum pyramidale of the 
hippocampus. As shown in figure 12A the fEPSP potentials of WT animals showed a 
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potentiation of 20 % after HFS and both HET and KO animals presented with slightly 
increased potentials. During the whole recording time no significant difference were 
observed between genotypes (WT 121 ± 8.17%; HET 133 ± 4.65%; KO 132 ± 6.55%; 
two-way ANOVA F = 0.70; p = 0.51; n = 12/12/11; N = 6/6/6). 
 
 
The PS amplitudes recorded in the pyramidal layer of WT and HET mice showed a 
potentiation of around 340 % after high frequency stimulation (figure 12B; WT = 341.0 
± 26.6%; HET = 331.0  ± 13.1%). There was no significant difference between these 
two genotypes for the whole recording time and after one hour both showed a similar 
potentiation (figure 12B; WT = 292.0 ± 18 %; HET = 305.0 ± 20.3 %). Recordings of 
FIGURE 12: LTP RECORDINGS OF PV-KCC2 MICE. A| fEPSP amplitudes did not 
differ between WT, HET and KO during LTP recordings in the str.radiatum; two-way 
ANOVA p = 0.5083. B| Slices from PV-KCC2 KO animals showed decreased population 
spike amplitudes after HFS; two-way ANOVA p = 0.01; n = 12/12/11; N = 6/6/6 C| Mean 
of PS amplitudes recorded during the last 5 min of LTP. KO slices presented smaller 
amplitudes than WT and HET slices; Bonferroni’s multiple comparison test WT vs. HET 
p > 0.05; WT vs. KO p < 0.0001; HET vs. KO p < 0.0001. n= 8/8/8; N = 4/4/4.  
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KO mice showed a decreased potentiation after HFS (KO = 220.0 ± 19.2 %) and 
analysis with two-way ANOVA showed a significant difference over the complete 
recording time (F= 5.516; p = 0.01; n = 8/8/8; N = 4/4/4). 
The mean of PS amplitudes - normalised to the baseline - during the last 5 min was 
determined (figure 12C). One-way ANOVA revealed a significant difference (F = 119.8; 
p < 0.0001). Bonferroni’s multiple comparison test calculated no difference between 
WT and HET (WT = 297.0 ± 4.1 %; HET = 308.5 ± 4.3 %; p > 0.05), but confirmed the 
decrease PS amplitude potentiation in KO (KO = 223.0 ± 4.4 %; WT vs. KO p < 
0.0001; HET vs. KO p < 0.0001). 
FEAR CONDITIONING 
Fear conditioning is a form of one-trial learning (Fanselow, 1990). Only one 
conditioning session is necessary to induce a robust and long-term behavioural 
change; thus, fear conditioning serves as a model to clarify the electrophysiological and 
molecular mechanisms underlying learning. To determine whether the KO of KCC2 in 
parvalbuminergic neurons regulates additional forms of hippocampus-dependent 
memory, aversive contextual fear conditioning (Phillips and LeDoux, 1992) was 
studied. In figure 13 the applied protocol (figure 13A-C) and corresponding results 
(figure 13D-F) are illustrated. The tables with the detailed results for every time point 
are present in the appendix. During acquisition, all groups showed progressively 
increasing levels of freezing after application of the auditory cue and foot shock (figure 
13D), indicating that they successfully acquired the task. There was no difference in 
acquisition between WT and HET mice, but KO mice showed an increase in freezing 
 
 
43 
 
time (two-way ANOVA F=9.484; p=0.0005; N = 12/12/12) that became significant 
before the neutral auditory cue (CS) was presented after 180 s (WT = 5.085 %, KO = 
16.48 %, Bonferroni’s multiple comparison test p < 0.05). 
 
FIGURE 13: CUED AND CONTEXTUAL FEAR CONDITIONING. A| Acquisition 
protocol at day 1. The period of the tone is illustrated in red, time point of the foot 
shock in blue. B| 24 hours after the acquisition, the cued test was carried out followed 
by C|, the context test. The corresponding results of fear conditioning of PV-KCC2 
mice are shown in the lower panel. D| During acquisition PV-KCC2 KO mice showed 
an increased freezing behaviour already before application of CS or US. E| 24 h after 
acquisition the mice were placed in a new context and the CS was applied after 180 s 
(red). All genotypes show a similar waveform, but PV-KCC2 KO mice demonstrated an 
upward shift, * two-way ANOVA p = 0.003. F| When returned to the acquisition 
context, all genotypes showed elevated freezing levels compared to the acquisition 
trial and KO mice showed a significant increase in the freezing behaviour compared to 
WT and HET animals, * two-way ANOVA p = 0.03, N = 12/12/12, # Bonferroni’s post-
test. 
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To assess the cued fear memory the mice were placed in a new context 24 h after fear 
acquisition and were allowed to explore this new context for 180 s. During this time, 
period baseline freezing was determined in the new environment. WT and HET mice 
showed freezing between 20 and 30 % of the time assessed (WT 26.6 ± 3.4 %; HET = 
28.6 ± 3.8 %), whereas KO animals were more anxious in the new context (KO = 39.7 ± 
4.3 %). The rise in freezing time after application of CS was analysed separately and 
revealed a similar increase of around 50 % in all genotypes (figure 14: Δtf (%): WT = 38.8 
± 4.3 %; HET = 34.2 ± 4.6 %; KO = 41.9 ± 4.9 %; one-way ANOVA F = 0.079; p = 0.92; 
N = 12/12/12). This increase in freezing time was followed by a slow recovery to 
baseline. WT and HET displayed a comparable curve shape whereas KO mice show 
significantly elevated levels of freezing time at nearly all investigated time points (two-
way ANOVA F = 67.00; p = 0.003; figure 13E). 
To measure contextual fear memory, mice were put back to the training context 2 h after 
completion of the cued testing. The memory of the foot shock related context was intact 
in all genotypes which was evident by an increase of the freezing time compared to the 
freezing time during acquisition. WT and HET animals showed freezing during 40–60 % 
FIGURE 14: RISE OF FREEZING TIME 
DURING CUED TEST. Analysis of the 
rise in freezing time after application of CS 
during cued test. No significant difference 
was detected between genotypes, p=0.92.  
Δtf   change of freezing time. 
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of the time period analysed, which is comparable with results from other studies with a 
similar protocol (Ikegami et al. 2014). In contrast, KO mice spent around 50–80 % of the 
time freezing in the context test, which was significantly increased compared to WT and 
HET (figure 13F; two-way ANOVA F = 3.87 p = 0.031). 
PARVALBUMINERGIC NEURONS IN THE SUPERIOR COLLICULUS 
Shang et al. reported in 2015 that PV+ neurons in the superior colliculus (SC) 
contribute to a subcortical visual pathway that transmits threat-relevant visual 
information to the amygdala to trigger fear responses. These PV+ neurons are 
predominantly glutamatergic projection neurons. To verify whether the PV+ neurons in 
the SC are GABAergic and whether the KCC2 knockout was effective, sagittal brain 
slices were stained with antibodies against KCC2, parvalbumin and GABA. 
As shown in figure 15 A the adjacent cortical area (retrosplenial granular cortex) of the 
SC was used as an internal control. In the retrosplenial granular cortex neurons stained 
for parvalbumin (green) were also positive for GABA (red) as expected for 
parvalbuminergic interneurons (figure 15C). In addition, some neurons were found that 
were positive for GABA but not for PV, representing other subgroups of inhibitory 
neurons in this area. In the superior colliculus the parvalbumin and the GABA signal did 
not overlap; there were either PV+ neurons or GABAergic neurons. These observations 
are consistent with published data (Shang et al., 2015). Slices from the same mice 
were taken to verify the knockout of KCC2 in these neurons. 
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FIGURE 15: STAINING OF PV+ INTERNEURONS IN THE SUPERIOR 
COLLICULUS AND ADJACENT CORTICAL AREAS. A| Scheme of sagittal brain 
section with detailed positions of the pictures displayed in B and C. BI Co-staining of PV and 
KCC2 in neurons of SC. In WT mice neurons show KCC2 staining at the plasma membrane 
(arrow) and in KO animals this signal was absent. Scale bar 10 µm. C| Sagittal sections were 
stained with anti-PV and anti-GABA antibodies. In cortical areas there is a colocalisation, all PV 
positive cells are GABAergic representing parvalbuminergic interneurons (arrows). Some 
GABA positive neurons (grey arrow heads) did not stain for parvalbumin. In the SC PV positive 
cells are negative for GABA (stars). Scale bar 20 µm. Ctx cortex; GABA γ-Aminobutyric acid; 
KCC2 potassium chloride cotransporter 2; PV parvalbumin; SC superior colliculus. 
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As shown in figure 15B, parvalbuminergic neurons of the SC express KCC2 at the 
plasma membrane in WT whereas neurons of KO tissue lack KCC2. Ralf Dittmann 
already quantified the knock out efficiency. His calculation revealed an ablation of 
KCC2 expression in around 60% of all cortical PV+ neurons (WT = 77.9 ± 1.5 %; KO = 
18.1 ± 1.3 %; Students t-test p < 0.0001; n = 6/6: N = 3/3) and a 50 % decrease of 
KCC2 mRNA expressing PV+ neurons (WT = 84,7 ± 1,9 %; KO = 42,2 ± 4,6 %; 
Students t-test p < 0,0001; n=9/6; N = 1/1). 
SERUM CORTICOSTERONE LEVELS 
Since KO mice showed increased freezing levels even at baseline conditions serum 
corticosterone levels were analysed by ELISA. 
The measurement of the supplied standards resulted in a standard curve that was fitted 
by exponential regression analysis (figure 16A). The formula of the regression line 
(y=76631*e-0.087*x) was used to determine sample concentrations. 
As shown in figure 16B, WT animals had low CORT concentrations (WT=1748.1pg/mL 
± 286.4; N=8), in agreement with a resting, quiescent state. Serum CORT levels of KO 
mice were significantly higher during this resting state (KO = 4806.5 pg/mL ±1037.0; 
N=9; students t-test p = 0.016). 
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FIGURE 16: SERUM CORTICOSTERONE LEVELS. A| Standard curve of the 
corticosterone (CORT) ELISA. The exponential regression line (y= 76631*e-0.087*x) 
was used to calculate the CORT levels from serum samples. B| Serum CORT levels of 
WT and PV-KCC2 KO mice. KO mice showed a significant elevation of serum CORT 
levels at resting state (WT = 1748.1 pg/ml ± 286.4; KO = 4806.5 pg/ml ±1037.0; 
n=8/9; Students t-test p = 0.016). 
 
MORPHOLOGY OF PARVALBUMINERGIC INTERNEURONS 
KCC2 has been reported to interact with the cortical actin cytoskeleton and thus 
contributes to the cellular architecture (Chamma et al., 2012). Therefore, we addressed 
whether the structure of PV+ interneurons is affected by the knockout of KCC2. 
tdTomato expressing PV+ interneurons of the hippocampal CA1 region were analysed. 
There was no obvious difference in the shape or size of the soma (WT = 16.43 ± 0.68 
µm, KO = 16.06 ± 0.70 µm, n = 22/22, students t-test p = 0.7) of PV+ interneurons 
between WT and KO. The number of basal dendrites - the dendrites emerging from the 
soma of the cell - was analysed in the CA1. KO animals did not display an alteration of 
the number of basal dendrites (figure 18; WT = 4.07 ±0.11; KO = 3.92 ± 0.12; students 
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t-test p = 0.2; n=4/4). Due to the excessive density of PV+ fibres in this region the 
analysis of dendritic branching was not possible since most of the time dendrites could 
not be clearly followed up  to its  soma. Patching and filling of PV+ neurons with Lucifer 
yellow did not improve the visibility of single fibres. 
 
 
LOSS OF PV+ INTERNEURONS  
To assess whether there is a reduction in the number of the PV+ interneurons, brain 
slices were analysed at three different time points. Mice at 4 weeks of age were 
analysed because at this time point PV Cre expression was fully established (Lecea et 
al., 1995, Hippenmeyer et al., 2005) and motor deficits were not observed. At 8 weeks 
of age, the phenotype was fully established and most electrophysiological recordings 
were done at this age. At the age of 23 weeks, most of the PV-KCC2 KO mice show a 
very severe phenotype. Therefore, those two time points were analysed additionally. 
FIGURE 17: ANALYSIS OF THE MORPHOLOGY OF PV+ INTERNEURONS.
Representative images of PV+ interneurons in the CA1 of hippocampus, PV+ interneurons of 
PV-KCC2 KO do not show differences in shape or size of the soma or alterations in the number 
of basal dendrites, shown by the white arrowheads. Bar diagram represents the number of 
basal dendrites per interneuron, n = 62/53, N = 4/4. Scale bar 20 µm. 
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At the age of 4 weeks no significant difference was observed in the number of PV+ 
hippocampal interneurons (figure 18A; WT = 82.3 ± 4.2; HET = 79.3 ± 2.8; KO = 79.5 ± 
4.5; one-way ANOVA F = 1.32; p = 0.28; n = 19/17/20, N = 4/3/4). At the age of 6 to 8 
weeks, when the phenotype is fully established, a significant loss of 10-15 % of PV+ 
interneurons in the hippocampus was observed for KO (WT = 87.5 ± 3.6; HET = 84.1 ± 
2.9; KO = 70.8 ± 2.8; one-way ANOVA F = 9.11; p = 0.0004; n = 19/18/18; N = 4/3/3). 
Tukey’s multiple comparison test revealed a difference between both WT and KO (p < 
0.001) and HET and KO (p < 0.01), but not for HET compared to WT (p > 0.05). With 
23 weeks of age there was a reduction of 13 % in HET and even 28 % in KO (WT = 
85.4 ± 4.9; HET = 74.7 ± 3.0; KO = 60.6 ± 3.4; one-way ANOVA F = 9.91; p = 0.0002; 
n = 21/23/18; N = 4/4/3). Post-tests showed significant differences between WT and 
KO (p < 0.001) and HET and KO (p < 0.05), but not for HET compared to WT (p > 
0.05). Statistical analysis was also performed for each genotype separately (figure 
18B). The number of PV+ interneurons did not differ between the 3 time points in WT 
(WT4weeks = 82.3 ± 4.2; WT8weeks = 87.5 ± 3.6; WT23weeks = 85.4 ± 4.9; ANOVA F = 
1.417; p = 0.25; N = 4/4/4) and one-way ANOVA also showed no significant loss of PV+ 
interneurons in HET mice over time (HET4weeks = 79.3 ± 2.8; HET8weeks = 84.1 ± 2.9; 
HET23weeks = 74.7; F = 2.073; p = 0.14; N = 3/3/4). For KO animals the decrease in the 
number of hippocampal PV+ interneurons was confirmed (KO4weeks = 79.5 ± 4.5; 
KO8weeks 70.8± 2.8; KO23weeks = 60.6 ± 3.4; one-way ANOVA F = 5.59; p = 0.006: N = 
4/3/3). 
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The cortex was additionally analysed. However, no significant differences could be 
observed in the total number of PV+ interneurons at all 3 time points (figure 19A; 4 
weeks n = 16/15/16, N = 4/3/3; 8 weeks n = 19/22/18, N = 4/4/3; 23 weeks n = 
FIGURE 18: QUANTIFICATION OF PV+ INTERNEURONS IN THE 
HIPPOCAMPUS. A| Analysis according to age. Number of PV+ interneurons per 
slice did not differ at 4 weeks but decreased at 8 weeks of age (one-way ANOVA F = 
9.11; p =0.0004). In KO mice the loss was even more pronounced at 23 weeks (one-
way ANOVA F = 9.909; p = 0.0002) B| Analysis of the number of PV+ interneurons 
over time per genotype. WT and HET mice showed no change, a progressive 
reduction was detected only in KO animals (one-way ANOVA F = 5.59; p = 0.006). 
*one-way ANOVA, # Tukey’s multiple comparison test. 
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20/21/18; N = 4/4/3). Therefore, the number was analysed for different cortical layers 
that were defined by staining with DAPI (figure 19B). At all investigated time points the 
number of PV+ interneurons did not differ in all cortical layers of WT slices. As seen in 
figure 20C there is no difference between genotypes in layer II-III, neither at 4 weeks 
(one-way ANOVA F = 0.336; p = 0.72), 8 weeks (F = 1.087; p = 0.34) nor 23 weeks (F 
= 1.567; p = 0.22). In layer IV the numbers of PV+ interneurons did not change at all 
time points analysed (4 weeks: F = 0.4125; p = 0.66; 8 weeks: F = 0.8083; p = 0.45; 23 
weeks: F = 0.1776; p = 0.84). A decrease in PV+ interneurons was only detected in 
layers V-VI (figure 19C): at the age of 4 weeks the number was similar (F = 0.6073; p = 
0.55), but at 8 week KO animals showed reduced numbers in layers V-VI (WT = 13.1 ± 
0.6; HET = 12.2 ± 0.6; KO = 9.9 ± 0.6; one-way ANOVA F = 7.198; p = 0.002). This 
reduction was also present at 23 weeks (WT = 14.6 ± 1.9; HET = 13.9 ± 0.9; KO = 10.7 
± 0.5; one-way ANOVA F = 3.205; p = 0.04) but in contrast to the hippocampus there 
was no progression. 
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FIGURE 19: QUANTIFICATION OF PV+ INTERNEURONS IN THE 
SOMATOSENSORY CORTEX. A| Total number of PV+ interneurons per 100000 µm² was 
not different at all investigated time points. B| Representative pictures of quantification. For the 
layer specific analysis the channels of the pictures were split, maps of single layers were 
defined in the DAPI channel and transferred to the PV channel. Scale bar 50 µm. C| Numbers of 
PV+ interneurons in layers II-III, IV and V-VI. A reduction was detected only in layers V-VI in KO 
animals of 8 and 23 weeks of age; (one-way ANOVA 8weeks p = 0.0018; 23weeks p = 0.0487). 
In WT and HET animals, a decrease of the number of PV+ interneurons was not detected in all 
cortical layers at every time point. 
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EXCITABILITY 
EPSP – TO – SPIKE COUPLING 
To investigate the changes in excitability over time E-S coupling was recorded in acute 
brain slices of WT, HET and KO mice at either 8 or 23 weeks of age. The slope of the 
fEPSP recorded in the stratum radiatum and the amplitude of the PS recorded in the 
stratum pyramidale were analysed. Exemplary traces of all genotypes are shown below 
(figure 20A, B). In 8 week old mice (n = 14/17/17; N=4/4/4) slopes of fEPSPs increased 
with rising stimulus intensities and no significant differences were seen between 
genotypes (figure 20C; two-way ANOVA F = 1.196; p = 0.31). The amplitudes of WT 
and HET PS also rose similarly with ascending intensities; however, KO animals 
presented with smaller amplitudes than HET and WT mice (figure 20D; two way-
ANOVA F = 4.633; p = 0.01). Spike generation from the EPSP was analysed by 
plotting the amplitudes of the population spikes in the pyramidal cell layer against the 
EPSP slope at the stratum radiatum of CA1. KO mice showed a decreased E-S 
coupling compared to WT and HET animals. In KO samples, small fEPSPs (slope 0.5 
mV*ms) already lead to PS amplitudes of only half of the size of WT mice (WT = 1.8 ± 
0.27 mV; HET = 1.4 ± 0.16 mV; KO = 0.97 ± 0.09 mV) and with increasing slopes of 
fEPSPs the reduction in PS amplitude accelerated (figure 20E; F = 20.44; p < 0.0001).  
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FIGURE 20: FEPSP - TO - SPIKE COUPLING (E-S COUPLING). A| Exemplary 
traces of fEPSPs and PS recorded from WT, HET and KO slices from 8 weeks old 
mice. B| Exemplary traces of fEPSPs and PS of slices from 23 weeks old mice. C| 
fEPSP slopes of slices from 8 weeks old mice D| PS amplitudes of 8 weeks old WT, 
HET and KO mice. Knockout mice showed a decrease in PS amplitude, p= 0.0002. E| 
E-S coupling at 8 weeks of age. KO animals show decreased amplitudes, p < 0.0001. 
F| fEPSP slopes slices from 23 weeks old mice. G| PS amplitudes were increased in 
HET and KO animals at 23 weeks of age, p = 0.0002. H| E-S coupling of 23 weeks old 
mice revealed an increase of PS amplitudes in HET and KO, p < 0.0001. 
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At the age of 23 weeks (n = 24/24/34, N=5/5/5) the same experimental procedure lead 
to a very different result. Slopes of extracellular fEPSPs were still similar in all 
genotypes (figure 20F; two-way ANOVA F = 1.470; p = 0.24) and comparable to 
fEPSPs recorded from young animals. At all stimulus intensities analysed, the PS 
amplitudes of 23 weeks old KO mice were increased compared to WT and HET (figure 
20G; two-way ANOVA F = 9.604; p = 0.0002) in contrast to the recordings in 8 weeks 
old mice. If PS amplitudes were plotted against fEPSP slopes the upward shift of PS–
EPSP curve in both HET and KO group was striking demonstrating an enhanced EPSP 
to spike (E–S) coupling. The increase of E-S coupling in HET and KO could be 
statistically confirmed (figure 20H; two-way ANOVA F = 66.43; p < 0.0001). 
SEIZURE SUSCEPTIBILITY 
To assess the in vivo consequences of KCC2 loss in PV+ neurons on seizure 
susceptibility  seizures were induced with pentylenetetrazole (PTZ) in 23 weeks old 
mice (N = 4/4/4). After injection, the mice were videotaped. Analysis of the time from 
the injection until start of the different seizure states revealed a significant difference 
between genotypes (figure 21).  
Myoclonic jerks of KO mice started 93.0 ± 12.2 s after PTZ injection and therefore the 
latency was more than doubled compared to WT animals (WT = 38.3 ± 3.8 s; HET = 
48.3 ± 6.4 s). PV-KCC2 KO animals displayed a delay not only in the onset of 
myoclonic jerks, but also a significant delay for clonic and tonic-clonic phases of 
seizures could be observed (two way ANOVA F = 12.21; p = 0.005). 
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FIGURE 21: SEIZURE 
SUSCEPTIBILITY. 
PTZ injections induced epileptic 
seizures in all mice, but PV-KCC2 
knockout animals displayed a significant 
delay in onset of all seizure phases 
(two-way ANOVA F = 12.21; p = 0.005; 
N = 4/4/4). 
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DISCUSSION 
Brain activity is a functional interplay of excitatory and inhibitory neurons and neuroglial 
cells.  One prerequisite for a proper neuronal function is the homeostasis of intra- and 
extracellular ion concentrations. To establish a fine tuned inhibition and information 
processing, Clˉ homeostasis is essential (Blaesse et al., 2009, Buzsaki et al., 2007, 
Kaila et al., 2014a, Kaila et al., 2014b, Payne et al., 2003). In this study, the effects of 
KCC2-loss in a specific subset of neurons - namely PV+-interneurons - were 
characterised. The discussion of the results consists of three parts, one part deals with 
general observations, learning and memory, the second section focusses on 
electrophysiological changes and the third part addresses the epileptic phenotype of 
the conditional knockout mice. 
PHENOTYPICAL CHARACTERISATION 
In the investigated mouse model, the KCC2 protein was deleted in PV+ cells only. 
These GABAergic neurons account for 10-20 % of the neuron population (Freund and 
Buzsaki, 1996) and represent the largest interneuron subpopulation (Desiderato et al., 
1966, Riccio et al., 1992). In the hippocampal area CA1 11 % of neurons are 
GABAergic, and 24 % of those are PV+; thus, PV+ interneurons represent only 2.6% of 
the total neuronal population (MacKenzie and Maguire, 2015).  
Homozygous PV-KCC2 KO mice present with a decreased life span and an impaired 
motor function, which was not observed in HET animals. This suggests that 50 % of the 
KCC2 protein does not severely interfere with the function of inhibitory neurons. 
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Because of the widespread distribution of PV+ neurons in nearly all areas of the brain 
(Lissek, 2012), the specific cause for the general phenotype like shortened life span, 
reduced body weight and motor impairment is difficult to assess. 
Functional alterations or a change in the number of PV+ interneurons were reported to 
be associated with a broad spectrum of both psychiatric and movement disorders 
(Cheah et al., 2012, Marín, 2012, Kalanithi et al., 2005, Gernert et al., 2000). Since 
GABA is the major inhibitory neurotransmitter in basal ganglia, where GABAergic 
pathways mostly dominate information processing, abnormalities of GABAergic 
transmission are key elements in pathophysiologic models of movement disorders 
(Kelso et al., 1986). Basal ganglia include the striatum, globus pallidus, substantia 
nigra and subthalamic nucleus. The most abundant neuronal cell type in the striatum 
are GABAergic medium spiny neurons. These striatal neurons receive inputs from the 
cerebral cortex, thalamus and several classes of local interneurons (Malinow and 
Miller, 1986). A reduction of PV+ interneurons in the striatum leads to a reduced activity 
of basal ganglia – by reduced inhibition and the consequent activation of striatal 
GABAergic projection neurons - and thereby causes idiopathic dyskinesia with 
paroxysmal dystonia (Fanselow, 1980). 
The loss of PV+ striatal interneurons in the striatum was also reported to contribute to 
dystonia in patients with Huntington’s disease (HD) (Bliss and Collingridge, 1993). Mice 
expressing human mutant superoxide dismutase (SOD)1, representing a widely 
investigated model of the familial form of the neurodegenerative disease amyotrophic 
lateral sclerosis (ALS), show an increase of PV+ cortical interneurons in the motor and 
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somatosensory areas of the cortex compared to wild-type littermates (Lissek et al., 
2013). 
The motor phenotype of our KO mice could also arise from disturbed inhibition of motor 
neurons that establish the information transfer from the motor cortex via the spinal cord 
to the skeletal muscles. In motor neurons, located in the primary motor cortex or 
anterior grey column of the spinal cord, less inhibition can lead to a rapid series of 
action potentials and therefore tetanic contractions of downstream muscle fibres. 
Proprioceptive afferents of type Ia also express PV (Celio, 1990, Sonner et al., 2017). 
These primary sensory fibres are sensitive to muscle length and speed of muscle 
lengthening (Tresilian, 2012), and are possibly affected by the KCC2 knockout in our 
mouse model. Type Ia afferents from the muscle spindle terminate on proximal 
dendrites of α-motor neurons (Jones, 2011) and can thereby stimulate the contraction 
of innervated muscles. If the inhibition is disturbed in type Ia fibres due to an increased 
Clˉ concentration, the targeted α-motor neurons may get hyper-activated, which may 
lead to spasticity of the downstream muscle fibres. This was already discussed for K+-
Clˉ-cotransporter 3 (KCC3) knockout in PV+ neurons, a mouse model with a similar 
motor phenotype. Ding and Delpire deleted KCC3 in different neuronal populations with 
subtype specific Cre lines and identified the PV+ cells as phenotype causing neuron 
subtype (Ding and Delpire, 2014). 
Mice with depletion or loss of Ia axons have been reported to develop abnormal, 
athetotic movements when walking (Brandalise et al., 2016, Kim et al., 2015). 
Therefore, the motor phenotype observed in our mice probably may result from 
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disruption of KCC2 in proprioceptive DRG neurons, which should be confirmed in 
further studies. A cerebellar contribution to the locomotor phenotype is less likely since 
specific KCC2 knockout in granule cells (GCs) or PV+ Purkinje cells (PCs), the two 
main target cell types of synaptic inhibition in the cerebellum, did not elicit motoric 
deficits (Seja et al., 2012). 
A possible explanation for the smaller statue of KO mice might be linked to the pituitary 
gland and its role in growth hormone regulation. The pituitary gland is part of the 
hypothalamic pituitary adrenal (HPA) axis, the major mediator of endocrine responses 
to stress (Aguilera, 2012). Stimulation of a specific group of neurons located in the 
dorsomedial parvocellular subdivision of the paraventricular nucleus (PVN) of the 
hypothalamus induces secretion of the hypothalamic peptide corticotropin-releasing 
hormone (CRH) and, to a lesser extent, vasopressin (VP). CRH and VP are released 
into the pituitary portal circulation and stimulate corticotropic cells in the anterior 
pituitary gland. These cells then release adrenocorticotropic hormone (ACTH) into the 
peripheral circulation. The release of ACTH stimulates cells of the adrenal cortex to 
produce and secrete glucocorticoids, which are essential for the metabolic adaptation 
to stress (Aguilera, 1994, Antoni, 1986, Aguilera, 2012). 
As discussed previously the HPA axis is subject to GABAergic inhibitory control from 
the prefrontal cortex and ventral hippocampus (Luscher et al., 2011). Prolonged 
activation of the HPA axis leads to suppression of growth hormone (GH) and inhibition 
of insulin-like growth factor-1 (IGF-1) effects on target tissues (Bailey et al., 2013). The 
impairment of normal growth and weight development in KO animals is obvious. 
Weight differs significantly around two months after birth, when Cre expression has 
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reached a plateau and the knockout of KCC2 in PV+ interneurons is fully established. 
This suggests that the altered chloride levels in affected interneurons and the 
consequently disturbed GABAergic inhibition may lead to malfunction of the HPA axis 
and thus results in disturbed levels of GH and growth retardation. 
It has already been reported that extreme stress can affect growth in humans e.g. 
suffering from Kaspar Hauser syndrome. This syndrome is also called psychosocial 
dwarfism (PD) and associated with severe childhood or adolescent short stature and/or 
delayed puberty due to emotional deprivation or stress. They present with apparent 
idiopathic hypopituitarism, unusual behaviour and a stressful home environment 
(Skuse et al., 1996). The underlying mechanism for the growth retardation in these 
patients seems to be an altered hypothalamic growth hormone-releasing hormone 
(GHRH) secretion that is controlled by CRH neurons via direct synaptic mechanisms 
(Peroski et al., 2016). This circuitry additionally plays a major role in anxiety and 
affective behaviour. A comparable mechanism could lead to the reduced weight and 
size of PV-KCC2 KO mice. 
To address the HPA axis function in our mouse model, corticosterone levels were 
determined from plasma of WT and KO mice. KO mice had increased serum 
corticosterone levels compared to WT animals (figure 17), suggesting an activation of 
the HPA axis. 
The fear conditioning data (figure 13 and 14) are consistent with increased stress 
levels in KO mice. During the acquisition at day one, animals of all genotypes showed 
a similar behaviour in the first 60 s, moving around to explore the new environment. 
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The mice had in total 3 min prior to tone administration to adapt to the experimental 
setup. During the second and third minute KO animals already showed an increased 
freezing time although there were no cues presented. In all following trials KO mice 
presented with higher freezing levels compared to WT and HET. Key players in the 
generation of fear and the so called fight-or-flight response are the amygdaloid 
complex and the associated pathways like the superior colliculus (SC) – parabigeminal 
nucleus (PBGN) pathway that triggers fear response (Shang et al., 2015, Steimer, 
2002). Since PV+ interneurons display one of the biggest interneuron populations in the 
basolateral amygdaloid nucleus (BLA) (McDonald and Mascagni, 2001, Bocchio et al., 
2015), they play an important role in controlling emotional behaviour by regulating the 
activity of principal neurons (Wolff et al., 2014, Povysheva et al., 2006). They are 
thought to be involved in the control of fear by targeting the perisomatic region of 
principal neurons (Bienvenu et al., 2012), inhibiting and synchronizing their firing 
(Popescu and Paré, 2011, Wolff et al., 2014). Although PV+ interneurons are rare in the 
central nucleus of amygdala (CeA) (Zahm et al., 2003), their function in the central 
nucleus of amygdala has been shown to be related to anxiety-like behaviour (Wang et 
al., 2016, Ravenelle et al., 2014).  
This susceptibility to fear induction might result from the overactivation of excitatory 
PV+ projection neurons of the superior colliculus (SC) which are essential for detecting 
looming objects and triggering fear responses (Shang et al., 2015). These 
glutamatergic PV+ projection neurons of the superficial SC project to different brain 
areas, including the parabigeminal nucleus (PBGN), an area connected to the 
amygdala. Activation of the PV+ SC-PBGN pathway triggers fear responses, induces 
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conditioned aversion, and causes depression-related behaviours. Approximately 20% 
of mice subjected to the fear-conditioning paradigm during the studies of Shang et al. 
developed a generalised fear memory. Immunohistochemistry confirmed that the PV+ 
neurons of the superficial SC are indeed affected by cell-specific KCC2 knock out 
(figure 15). This observation suggests a role of these glutamatergic PV+ neurons in the 
formation of the anxiety phenotype, in addition to the alterations of the GABAergic 
system and the disturbed HPA axis. 
During fear conditioning proper function of two major brain areas is essential, the 
amygdala for regulation of fear (Phillips and LeDoux, 1992, Phillips and LeDoux, 1994) 
and the hippocampus for the learning of the context in which a fearful event takes place 
(Phillips and LeDoux, 1992, Phillips and LeDoux, 1994). The hippocampus processes 
the context (shape, smell, colour, light of the box) and connects it to the aversive foot 
shock. The information of the foot shock is transmitted via the somatosensory cortex 
and thalamus to the lateral (LA) and central nucleus (CeA) of the amygdala. The 
information about the tone passes the auditory thalamus and the auditory cortex and is 
further relayed to the LA and is then integrated. A simultaneous interaction of both 
shock and tone induces neuronal plasticity in the LA and forms a link between tone and 
shock. The information is transmitted to the CeA which initiates vegetative processes 
like alterations in blood pressure and heart rate or the release of stress hormones 
(Medina et al., 2002). 
Neither the memory of the cue nor the memory of the context lead to an altered 
freezing reaction, hence the memory assessed by fear conditioning did not appear to 
be affected in KO mice. In figure 14 the increase in freezing time (Δtf) after tone 
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administration in a new environment illustrated a similar behaviour in all genotypes. 
Twenty-four hours after training, when placed in a novel testing context, KO mice 
exhibited  higher freezing rates than WT and HET mice (Pre-CS in testing, Figure 14). 
In other words, in KO mice the foot shock additionally induced conditioned fear to 
stimuli not associated with the aversive event, in this case a new environment. This 
generalisation phenomenon is defined by freezing when no acoustic CS is presented 
and outside of the conditioning context (Riccio et al., 1992, Desiderato et al., 1966, 
Fanselow, 1980). Fear generalisation engages similar neurocircuitries than implicated 
in the acquisition, expression and regulation of conditioned fear like the hippocampus 
and the amygdala (Lissek, 2012, Lissek et al., 2013, Dymond et al., 2015), but the 
precise role of the amygdala, hippocampal complex, medial prefrontal cortex, and other 
regions in mediating fear generalisation versus inhibition in humans requires further 
investigation.  
Other studies that focussed on the impact of KCC2 loss on learning, memory 
consolidation or mobility support this hypothesis. No difference could be observed 
between WT and HET in the Open field test with our mouse model. KO mice were 
excluded from the study because of the strong motor phenotype (Herrmann, 2015). In 
another study, Tornberg et al estimated exploratory activity and working memory of 
hypomorphic KCC2 mice by open field and Y-maze test. Such hypomorphic mice 
express 15–20 % of normal KCC2 protein levels in the CNS and show no impairment in 
working memory or exploration behaviour. Rearing activity of the KCC2hy ⁄ null mice did 
not habituate in contrast to WT mice, consistent with an increased anxiety. They 
confirmed the enhanced anxiety-like behaviour in the elevated plus-maze, where the 
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KCC2hy ⁄ null mice avoided entering the open arms almost completely (Tornberg et al., 
2005). Spatial learning and memory were tested for both of these mouse models and 
consistently found impairments during that learning task using the water maze. Since 
spatial navigation and consolidation of memory requires the function of the 
hippocampus, the performance of hypomorphic KCC2 or PV+-KCC2 knock out mice 
suggests a possible role for KCC2 in hippocampal learning. That hippocampal learning 
is affected in PV+-KCC2 mice seems reasonable, since the affected PV+ interneurons 
display around 20 % of GABAergic neurons and thereby represent the biggest 
subpopulation of inhibitory neurons of the hippocampus. The increased Clˉ 
concentration in PV+ interneurons might result in depolarising GABA action and thereby 
to increased GABA release and inhibition of downstream pyramidal cells. This could 
cause deficits in the synchronisation of the neurons that are required for a proper 
consolidation or storage of a new memory. 
ELECTROPHYSIOLOGICAL CHARACTERISATION 
Because of the observed differences in spatial memory, LTP was recorded in the 
hippocampus. After brief tetanic stimulation of Schaffer collaterals a sustained increase 
in synaptic transmission can be observed, which is referred to as long-term potentiation 
(LTP), representing the most widely studied correlate of memory (Bliss and 
Collingridge, 1993). The potentiation created in the dendritic layer represents the 
mostly excitatory answer of the pyramidal dendrites to the stimulus applied to the 
Schaffer collaterals. The interneurons, especially the PV+ interneurons, mainly project 
to the somata of pyramidal neurons located in the str. pyramidale. Therefore, it is not 
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surprising that the potentiation is not affected in the str. radiatum but decreased in the 
str. pyramidale of KO mice (figure 13). 
In our mouse model, only PV+ interneurons are affected by targeted KCC2 deletion and 
hence possibly changes in intracellular Clˉ concentration (Pellegrino et al., 2011, Rivera 
et al., 1999, Rivera et al., 2004). The measurement of intracellular Cl¯ concentration is 
still ongoing. Previous experiments by perforated patch clamp recordings with 
gramicidin did not show a difference of the Cl¯ reversal potentials (data not shown). 
Since gramicidin patch clamp recordings do not allow an efficient control over opening 
of the patch under the pipette, these results are uncertain. Recordings of the somato-
dendritic Cl¯ gradient are planned and the experimental settings of the uncaging setup 
are currently established.  
An  altered Clˉ  concentration can lead to a weaker efflux or even influx of Clˉ and 
thereby change the answer of neurons to GABA from inhibitory to excitatory (Hübner et 
al., 2001a, Jentsch et al., 2004, Stein et al., 2004, Rivera et al., 1999, Nardou et al., 
2011). In PV+ neurons this would lead to an increase of GABA release onto 
downstream pyramidal cells and increased inhibition. The elevated GABA release can 
enhance the hyperpolarising current in the postsynaptic pyramidal cell during the 
conditioning high frequency stimulus, which can block LTP induction (Malinow and 
Miller, 1986, Kelso et al., 1986). 
After tetanic stimulation the normal increase in the postsynaptic response is related to 
(i) presynaptic modifications that increase the amount of L-glutamate released per 
stimulus (ii) postsynaptic modifications like alterations in number or functional 
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characteristics of receptors, (iii) an extrasynaptic change, such as neurotransmitter 
uptake of glia cells, and (iiii) morphological modifications (Bliss and Collingridge, 1993). 
In our mouse model, KCC2 is only disrupted in PV+ neurons, so the excitatory 
presynaptic function of principal neurons should be intact. Still the increased GABA 
release by PV+ interneurons could affect the postsynaptic pyramidal neuron. The 
increased amount of GABA at the postsynapse might result in a smaller depolarisation 
and consequently missing reduction of the Mg2+ block from NMDA receptors, whose 
activation and NMDA receptor-dependent rise in postsynaptic Ca2+ are critical in LTP 
induction (Davies et al., 1991, Collingridge et al., 1988, Brandalise et al., 2016, Mulkey 
and Malenka, 1992). Since the GABAergic PV+ neurons mainly target the somata and 
axon initial segments of pyramidal cells (Cobb et al., 1995), the differences are 
restricted to the str. pyramidale. The dendritic signal transduction seems to work 
properly, since no differences could be detected in the str. radiatum. 
For memory formation and consolidation, a proper integration of spatial, contextual, 
and emotional information is necessary. In the hippocampus, this is done by the 
pyramidal cells that transmit the hippocampal output to various targets throughout the 
brain. The recorded signals in the str. pyramidale define the ouput of the hippocampal 
formation. Pyramidal cells in the CA1 and subiculum regions convey this output by 
firing action potentials after summation of all excitatory and inhibitory inputs. This 
summation takes place in the cell body of pyramidal neurons. Hence, the decrease of 
recorded amplitudes in the stratum pyramidale of KO slices might be a hint for an 
impaired memory function in PV+-KCC2 KO mice. The impaired spatial learning in HET 
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KCC2 knockout mice during water maze is in agreement with this result (Herrmann, 
2015). 
To further characterise the impact of the modulation of PV+ neurons several 
electrophysiological recordings were performed. Field potential and patch clamp 
recordings all point to an increased inhibition in PV+-KCC2 KO mice. As mentioned in 
the introduction the field potential recordings of Ralf Dittmann showed a decreased 
Paired-Pulse Ratio (PPR) in the hippocampus and the cortex of KO mice. These 
results indicate a reduced transmitter release and therefore an increased inhibition of 
presynaptic neurons in KO mice (O'Donovan and Rinzel, 1997). The so-called paired-
pulse depression (PPR<1) depends on both previous release and the residual Ca2+ 
concentration in the presynaptic terminal and can further be influenced by postsynaptic 
modifications of AMPA receptors. The altered Clˉ concentration in the PV+ interneurons 
leads to a switch from an inhibitory to an excitatory GABA response in these 
interneurons (Rivera et al., 1999, Hübner et al., 2001b, Stein et al., 2004, Nardou et al., 
2011) and consequently to an enhanced GABA release onto downstream pyramidal 
cells. This suggests an increased inhibition of pyramidal cells and could explain the 
smaller field potential amplitudes of the second pulse. The frequency of the network 
dependent inhibitory postsynaptic currents (sIPSCs) of pyramidal cells was shown to 
be increased in cortex and hippocampus in previous experiments in our lab (data not 
published), which is in agreement with the hypothesis of hyperactive PV+ interneurons 
and increased inhibition. 
To verify these results field potentials were recorded simultaneously from the str. 
radiatum and pyramidale and the fEPSP-to-spike coupling calculated. This allows a 
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statement on the information integration process. The conversion of EPSPs into action 
potentials is a fundamental property determining the coding of information in pyramidal 
cells (Konig et al., 1996). The recordings in the hippocampus of 8-10 weeks old mice 
showed no differences in fEPSP slope between genotypes but decreased population 
spike amplitudes in KO slices (figure 20C, D). When the simultaneously recorded 
values of fEPSP slope and PS amplitude were grouped and plotted against each other, 
the recordings from KO slices revealed an impaired EPSP-to-spike coupling (figure 
20E). In KO animals, the same amount of EPSPs - generated in the dendrites of 
hippocampal pyramidal cells - created smaller population spike amplitudes, suggesting 
that enhanced inhibition occurs at perisomatic regions of pyramidal cells.  
As mentioned before, the investigated mouse model shows spontaneous seizures and 
premature death at around 23 weeks of age. To identify the underlying cause for the 
disturbed excitation/inhibition balance, the numbers of PV+ interneurons in 
hippocampus and cortex were quantified and their morphology examined. The 
quantification showed a progressive loss of PV+ interneurons in the hippocampus and a 
small reduction in layer V-VI in the cortex of KO mice (figure 19). The result, which will 
be discussed in detail later, lead to the recording of EPSP-to-spike coupling in 21 
weeks old mice. The fEPSP slopes recorded in str. radiatum displayed no significant 
differences between genotypes (20F), like already seen in the young cohort. The 
associated population spike amplitudes increased in HET and KO mice and the 
correlation showed an amplified EPSP-to-spike coupling (figure 20G, H). Therefore, in 
HET and KO animals the same amount of EPSPs generated in the dendrites of 
hippocampal pyramidal cells creates bigger spike amplitudes. This suggests that the 
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former enhanced inhibition at perisomatic regions of pyramidal cells is diminished at 
the age of 23 weeks. The reduction of inhibition in the hippocampus can be explained 
by the smaller amount of PV+ interneurons at that age but it is also possible that the 
spontaneous seizures observed in KO mice lead to a progressive loss of interneurons. 
To date it is not clear, whether the reduction in the number of PV+ interneurons is the 
cause or the consequence of the seizure phenotype. The decrease could be caused by 
the enhanced activity which can lead to excitotoxicity, a type of neurotoxicity mediated 
by NMDARs and calcium ions, well studied for excitatory cells (Choi, 1985, Choi, 1987, 
Rubio-Casillas and Fernandez-Guasti, 2016, Lehmann and Jacobson, 1990). 
It has been proposed that excitotoxicity is caused by an excessive stimulation of 
neuronal excitation and that any source of excitation is potentially harmful (Lai et al., 
2014). Moreover, the initial calcium influx mediated by NMDARs following excitotoxic 
glutamate stimulation is known to trigger a secondary intracellular calcium overload, 
which correlates with neuronal death (Randall and Thayer, 1992, Tymianski et al., 
1993). Since the increased activation of PV+ interneurons likely relies on the Clˉ 
accumulation by deletion of KCC2 in these interneurons, the involvement of NMDARs 
is not likely in our mouse model. 
Conditions like acute (Yuen et al., 2009, Yuen et al., 2011) or chronic stress (Popoli et 
al., 2012) or seizure activity can lead to enhanced glutamate levels. This may trigger 
excitotoxicity in PV+ interneurons by activating NMDARs. The already ‘overactive state’ 
could contribute to an intracellular calcium overload resulting in neuronal death. 
Alternatively, the loss of PV+ interneurons could result from recurrent seizures. Many 
publications in rodents (Kobayashi and Buckmaster, 2003, Dinocourt et al., 2003, Sayin 
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et al., 2003, Huusko et al., 2015) and humans (de Lanerolle et al., 1989, Tóth et al., 
2010, Arellano et al., 2004, Zhu et al., 1997, Maglóczky and Freund, 2005, Maglóczky 
et al., 2000) have shown a reduction of GABAergic interneurons after epileptic 
seizures. This may result in insufficient GABA release and consequently a disinhibition 
of principal cells, which could promote the spread of seizure activity.  
Previous studies reported that a decreased number of GABAergic neurons reduces 
functional inhibition and increases excitability of principal neurons in the hippocampus 
of aged mice and that PV+ interneurons are more vulnerable to acute seizure activity 
than other interneuron subtypes (Weiss et al., 1990, Kuruba et al., 2011). This 
increased susceptibility might be explained by the extraordinary high energy 
expenditure of this neuronal subtype, which is able to generate fast series of action 
potentials and thus gamma oscillations (30–100 Hz) (Kann et al., 2014). Increased 
spiking rates during seizures can enhance oxygen and nutrient consumption and could 
lead to depletion of cellular energy substrates and ATP. Energy consuming processes 
include the release and metabolism of GABA, the restoration of membrane ion 
gradients and Ca2+-removal. As Kann et al discussed in detail, fast-spiking interneurons 
have unique electrophysiological and neuroenergetical properties that are different 
from principal cells or other interneuron subtypes and utilize much more energy than 
other cortical neurons. This might render them highly vulnerable to conditions of 
metabolic stress (Kann, 2016, Kann et al., 2014). In our mouse model a selective loss 
of PV+ neurons was found only in infragranular layer V and VI of the somatosensory 
cortex. These layers are composed predominantly of larger pyramidal cells that give 
rise to the major output pathways of the cortex, projecting to other cortical areas and to 
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subcortical structures (Kandel and Mack, 2014). The local PV+ interneurons are mostly 
basket cells, whose axons densely target the perisomatic compartments of principle 
neurons (Xiang et al., 2002). They regulate the information processing of these major 
output pathways of cortical layers V and VI (Naka and Adesnik, 2016, Briggs, 2010), 
which might require a higher activity compared to other cortical layers and therefore 
increases their sensitivity to stress.  
During recurrent seizures, increased activation of PV+ interneurons might result in 
cytosolic and mitochondrial Ca2+-overload that would also enhance the generation of 
ROS and NO (Eyles et al., Kovacs et al., 2005, Kovacs et al., 2002, Malinska et al., 
2010). Enhanced ROS generation combined with alterations of anti-oxidative 
mechanisms may cause higher levels of oxidative stress in fast-spiking interneurons as 
compared to other neuron subtypes, which might lead to damage of DNA and 
functional proteins, such as enzymes and ion channels (Behrens et al., 2007, Kann and 
Kovacs, 2007, Steullet et al., 2010).  In our mouse model PV+, interneurons are hyper-
activated as effect of the GABA mediated excitation. Therefore, the described 
mechanism of Ca2+-overload and increased oxidative stress may aplly to  this 
interneuron subtype prior to occurrence of seizures. This could explain the progressive 
reduction of PV+ interneurons in the hippocampus and the cortex.  
Another possibility that has to be considered is, that reduction of PV+ neurons cannot 
only be a result of neuron loss but also due to a reduction of the PV protein expression. 
Several publications indicate that seizure activity causes loss of PV immunoreactivity 
but not neuron loss (Sloviter, 1989, Scotti et al., 1997, Wittner et al., 2005, Wittner et 
al., 2001). Results from studies on PV-deficient mice show that low levels of 
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parvalbumin in the axon terminals correlate with increased GABA release indicating 
that PV modulates Ca2+-dependent GABA neurotransmission (Vreugdenhil et al., 
2003). A reason for the loss of PV-like immunoreactivity from some of these cells could 
be the transient stop of PV synthesis, or a conformational change induced by Ca2+-
overload of PV (Johansen et al., 1990, Scotti et al., 1997). To rule out this possibility, 
further studies should include the quantification of the total number of GABA 
immunoreactive neurons. More importantly, the quantification should be repeated with 
the PV-tomato-KCC2 mouse strain. The PV+ neurons remain tdTomato labelled even 
when PV expression is reduced and quantification of tomato positive cells should allow 
a reliable statement if there is indeed a reduction of PV+ interneurons in PV-KCC2 KO 
mice. 
EPILEPSY 
The spontaneous seizures and the early death of KO animals are the most striking 
phenotype of this mouse model. So far, three influencing factors have to be considered 
(figure 22): (I) stress, (II) loss of PV+ interneurons and (III) depolarising GABA actions.  
The enhanced corticosterone levels and anxiety-like behaviour are reported to fuel 
epileptic seizures (Joëls, 2009, MacKenzie and Maguire, 2015, Maguire and Salpekar, 
2013, O’Toole et al., 2014). Stress has been associated with altered GABAergic 
inhibition (Holm et al., 2011, Serra et al., 2008), decreased neurosteroid modulation 
(Dong et al., 2001) and induction of hippocampal damage/remodelling (McEwen, 1999, 
Mirescu and Gould, 2006, Fuchs et al., 2006) which may contribute to network 
hyperexcitability. Furthermore corticosterone, which was elevated in PV+-KCC2 
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knockout mice (figure15), has been reported to increase seizure susceptibility to 
kainate-induced seizures and kindling (Kling et al., 1993, Karst et al., 1999, Roberts 
and Keith, 1994, Kumar et al., 2007). Another interesting effect of long-term 
glucocorticoid exposure is the reduction of cell number in the hippocampus by 
suppression of adult neurogenesis or loss of cells (Mizoguchi et al., 1992, Sapolsky et 
al., 1985, Stein-Behrens et al., 1994, Paizanis et al., 2007). 
Moreover, PV+ interneurons can be affected by stress induced cell death (Czeh et al., 
2005, Hu et al., 2010), what might contribute to network dysfunction and 
hyperexcitability (figure 22). 
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FIGURE 22: FACTORS INVOLVED IN SEIZURE GENERATION.  
KCC2 knock out in PV+ interneurons causes Clˉ accumulation and depolarising GABA 
actions in PV+ interneurons. Therefore, inhibition onto pyramidal cells increases and 
the permanent increased activity could lead to the death of PV+ neurons. Loss of PV+
interneurons could increase excitation and seizure susceptibility. Increased inhibition 
could synchronise many brain areas or lead to Clˉ accumulation in downstream 
pyramidal cells and thereby trigger seizures. Moreover, the increased anxiety/stress
could fuel seizure generation or induce hippocampal cell loss, promoting epilepsy.  
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Loss of PV+ interneurons or loss of PV expression are associated with seizure activity 
(Schwaller et al., 2004, Andrioli et al., 2007, Sessolo et al., 2015, Yekhlef et al., 2015, 
Assaf and Schiller, 2016). One possible link is the importance of PV+ interneurons in 
the generation of oscillations and synchronisation of network activity. Oscillatory activity 
in the hippocampus is well studied and it arises from feedback connections between 
neurons, resulting in synchronisation of their firing pattern with different frequencies. 
PV+ interneurons have been associated with rhythmogenesis (Buzsaki and Eidelberg, 
1983, Cardin et al., 2009, Fuchs et al., 2001, Sohal et al., 2009) and hippocampal theta 
or gamma oscillations (Wulff et al., 2009, Amilhon et al., 2015). Our collaboration 
partner Dr. Dirk Isbrand from the University of Cologne recorded EEGs in anesthetised 
WT and KO mice, which reflect the activity of a large number of neurons and found a 
difference in the amplitude of theta waves and in theta-gamma coupling between 
genotypes (data unpublished). Theta waves - associated with active movements, 
interactions with the environment and REM sleep (Vanderwolf, 1969, Buzsáki, 2002) - 
showed a decrease in amplitudes in KO animals compared to WT, confirming the 
importance of PV+ related inhibition in theta rhythm generation (Amilhon et al., 2015, 
Klausberger et al., 2005). Gamma oscillations were not affected by KCC2-knock out in 
PV+ interneurons. Theta/gamma coordination, which is proposed to be important for 
encoding and preserving serial order of inputs, thus providing a way of representing 
items in short-term and working memory (Burle and Bonnet, 2000, Lisman, 2005, 
Lisman and Buzsaki, 2008, Lisman and Idiart, 1995), were also disturbed in the 
hippocampus of HET and KO mice. Hence, deficits in the coupling of the oscillations 
could lead to alterations in the hippocampal information processing, which may explain 
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the deficits observed during water maze in our mouse model. The KCC2 loss in PV+ 
interneurons and the resulting loss of inhibition could disturb the generation of the fine-
tuned theta oscillations and consequently alter network synchronisation. Wulff et al. 
already showed that fast inhibition of PV+ interneurons is critical for the generation of 
theta but not gamma oscillations and in the coupling of hippocampal rhythms across 
different frequency bands (Wulff et al., 2009). It would be interesting to know, if this 
leads to an altered synchrony between different brain areas, which is one mechanism 
proposed for seizure generation (Broggini et al., 2016, Warren et al., 2010). 
Furthermore, the increased inhibition in young animals could affect synchrony of 
network oscillations and consequently proper coordination of network activity. During 
the last decades, more and more reports were published on how altered GABAergic 
signalling participates in the generation of human epileptiform discharges 
(Schwartzkroin and Haglund, 1986, Cohen et al., 2002, Avoli et al., 2005) and how 
increased inhibition can promote the induction of seizures. Special attention was paid 
to the role of PV+ interneurons. 
PV+ interneurons, which are highly interconnected by both chemical and electrical 
synapses (Tamas et al., 2000, Gibson et al., 1999, Galarreta and Hestrin, 1999b), 
project to a large number of target cells and can synchronise large cell populations. In 
our mouse model only these interneurons are affected by cell-type specific KCC2 
knock out and alterations in the firing pattern or activity could influence synchrony of 
the innervated pyramidal cell populations.  
 
 
79 
 
Depending on the resting membrane potential and transmembrane gradient of Clˉ, 
GABA can either hyperpolarise or depolarise a postsynaptic neuron (Farrant and Kaila, 
2007, Kaila, 1994). Disinhibition of KCC2 deficient PV+ interneurons and subsequent 
increase in GABA release onto the downstream pyramidal neurons can stress Clˉ 
extrusion mechanisms in postsynaptic neurons (Payne et al., 2003, Blaesse et al., 
2009)  leading to intracellular Clˉ accumulation and a consequent depolarising shift of 
EGABA. Additionally, prolonged activity of GABAARs results in increased extracellular K+ 
levels via KCC2, thereby initiating a prolonged non-synaptic depolarisation (Viitanen et 
al., 2010). Both mechanisms could lead to excitation of a big cell population throughout 
different brain areas, starting an epileptic seizure. Interestingly, seizure induction with 
PTZ at the age of 23 weeks, when KO mice showed an electrophysiological increase in 
excitation, demonstrated elevated seizure thresholds (figure 21). This rather confusing 
result may suggest that in 23 weeks old KO mice disinhibition and consequently 
hyperactivation of PV+ interneurons causes Clˉ accumulation in downstream pyramidal 
cells and therefore a depolarising GABA action on excitatory cells. This may lead to 
increased excitation and seizure generation. The mode of action of PTZ is not clear, 
complicating the interpretation of the results. To get more insights, this experiment 
should be repeated in younger animals, when inhibition is increased, and, for both 
ages, with another convulsive compound. To get a better idea of the involved 
processes experiments with a younger cohort are pending on the permission from the 
Thüringer Landesamt für Lebensmittelsicherheit und Verbraucherschutz.  
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CONCLUSION AND OUTLOOK 
Many previous studies have underlined the importance of PV+ neurons for proper brain 
function. Most focussed on their role in a specific brain area. In our mouse model, 
however, all PV+ neurons are targeted. Therefore, alterations in different brain regions 
may contribute to the phenotype.  
We could show that changes in KCC2 levels in PV+ interneurons affect the excitability 
of this interneuron subtype with consequences for neuronal function. We observed a 
shortened life span, spontaneous epilepsy and a reduction of PV positive interneurons 
with 23 weeks. Unfortunately, we were not able to show the role of KCC2 for the 
regulation of the electrochemical chloride gradient in parvalbuminergic interneurons. 
In future studies, one should assess GABA-evoked chloride currents and evoked 
IPSCs (eIPSCs) of PV+ interneurons to confirm Clˉ accumulation. The somato-dendritic 
EGABA gradients may give a more reliable estimate of KCC2 extrusion capacity than 
static EGABA on the soma. The combination of perforated patch recordings of the latter 
with whole cell recordings of ΔGABA between soma and dendrites may provide 
important information regarding the consequences of KCC2 ablation in PV+ neurons.  
To verify, whether Clˉ accumulation in pyramidal cells are the cause of increased 
excitation at the age of 23 weeks, perforated patch recordings of pyramidal cells have 
to be conducted additionally. These results would allow a better understanding of 
GABA actions and the physiological synergy of excitatory and inhibitory neurons.  
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Since the inhibition is increased in 8 weeks old KO animals, a closer look into 
extrasynaptic GABAA receptors might be interesting. When more GABA is released 
due to enhanced PV+ interneuron activity, this ‘spillover’ from the synaptic cleft could 
activate extrasynaptic or perisynaptic GABAARs to generate a persistent or tonic 
inhibition (Belelli et al., 2009).  
To better characterise the molecular mechanisms of epileptogenesis the BDNF-TrKB-
KCC2 pathway and KCC2 phosphorylation patterns should be examined after 
controlled seizure induction in WT and KO animals. 
Further in vivo studies could elicit the impact of stress to seizure generation and 
susceptibility. Therefore, an accurate determination of corticosterone levels over time 
and an analysis of additional stress hormones like adrenalin are possible.  
The seizure threshold studies with PTZ should be repeated with mice of the age of 8 
weeks, and, additionally, with another compound that is not acting via the GABAA 
receptor. These experiments would allow a better interpretation of the observations. 
Future experiments will lead to a deeper insight into Clˉ homeostasis and 
epileptogenesis. 
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APPENDIX 
LIST OF GENE NAMES FIGURE 1 
Arx   aristaless related homeobox 
Upar Urokinase receptor, also called plasminogen activator, urokinase 
receptor (PLAUR) 
Dlx1,2   distal-less homeobox 1,2 
Cit-K   citron rho-interacting serine/threonine kinase 
Sox6   SRY (sex determining region Y)-box 6 
Cacnγ2  calcium voltage-gated channel auxiliary subunit gamma 2 
Gria4   glutamate ionotropic receptor AMPA type subunit 4 
Pick1   protein interacting with C kinase 1 
Elfn1 extracellular leucine rich repeat and fibronectin type III domain 
containing 1 
Bassoon  BSN, scaffolding protein 
Tnap   official ALPL, alkaline phosphatase, liver/bone/kidney 
Gad65   GAD2, glutamate decarboxylase 2 
Aldh5a1  aldehyde dehydrogenase 5 family member A1 
NHE1/SLC9A1 Na[+]/H[+] hydrogen exchanger 1 
GLUT1/SLC2A1 glucose transporter 1 
GAT1/SLC6A1 gamma-aminobutyric acid (GABA) transporter 1 
Eaat1/SLC1A3 Excitatory amino acid transporter 1 
Syn   Synapsin 
Snap25  synaptosome associated protein 25 
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Sv2a   synaptic vesicle glycoprotein 2A 
LGI1   leucine rich glioma inactivated 1 
STXBP1  syntaxin binding protein 1 
Nav   voltage gated sodium channel subunit 
Kv   voltage gated potassium channel 
KCNMA  potassium calcium-activated channel subfamily M alpha 1 
Hcn   hyperpolarization-activated, cyclic nucleotide-gated K+ 
GIRK2   KCNJ6, potassium voltage-gated channel subfamily J member 6 
CACNA1A  calcium voltage-gated channel subunit alpha1 A 
GabaR   gamma-aminobutyric acid (GABA) receptor 
GabaRb1  gamma-aminobutyric acid type A receptor beta1 subunit 
Kcc2   potassium-chloride cotransporter 2 
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RESULT TABLES FEAR CONDITIONING 
 
ACQUISITION 
time intervals (s) WT HET KO 
0-60 1.90 ± 0.99 0.32 ± 0.20 2.74 ± 0.70 
61-120 3.45 ± 0.77 2.98 ± 0.91 7.75 ± 1.92 
121-180 5.08 ± 1.92 4.60 ± 1.61 16.48 ± 3.39 
181-240 14.67 ± 4.88 10.75 ± 1.85 31.44 ± 5.31 
 
TABLE 4: FEAR CONDITIONING PV-KCC2 MICE; ACQUISITION. The table shows 
the time freezing (%) during the different stages of acquisition; tone started after 180s; 
foot shock was applied after 198s and lasted 2s. 
 
 
CUED TEST 
TABLE 5: FEAR CONDITIONING; CUED TEST. The table shows the time freezing 
(%) during the different time intervals of the cued test; tone started after 180s and lasted 
180s; no foot shock. 
time intervals (s) WT HET KO 
0-60 26.70 ± 5.20 18.74 ± 3.15 27.76 ± 4.07 
61-120 30.56 ± 3.83 33.38 ± 5.52 46.85 ± 5.87 
121-180 22.58 ± 3.15 33.65 ± 5.40 47.59 ± 5.87 
181-240 74.52 ± 3.73 74.29 ± 4.81 89.67 ± 1.71 
241-300 61.22 ± 4.54 65.28 ± 6.85 84.41 ± 4.65 
301-360 60.48 ± 6.11 51.76 ±6.64 79.17 ± 5.09 
361-420 32.05 ± 4.90 38.08 ± 9.42 59.74 ± 7.81 
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CONTEXT TEST 
time intervals (s) WT HET KO 
0-60 38.07 ± 4.91 46.58 ± 8.32 54.58 ± 6.25 
61-120 48.26 ± 6.51 55.69 ± 6.58 72.89 ± 7.46
121-180 37.18 ± 6.79 46.47 ± 7.71 66.86 ± 6.48
TABLE 6: FEAR CONDITIONING; CUED TEST. The table shows the time freezing 
(%) during the different time intervals of the cued test; tone started after 180s and 
lasted 180s; no foot shock. 
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